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This dissertation focuses on the development of magnetic resonance imaging (MRI)-
guided microwave thermal therapy systems for driving experimental studies in small animals, and 
to experimentally validate computational models of microwave ablation, which are widely 
employed for device design and characterization.  MRI affords noninvasive monitoring of spatial 
temperature profiles, thereby providing a means to to quantitatively monitor and verify delivery of 
prescribed thermal doses in experimental studies and clinical use, as well as a means to validate 
thermal profiles predicted by computational models of thermal therapy.  
A contribution of this dissertation is the development and demonstration of a system for 
delivering mild hyperthermia to small animal targets, thereby providing a platform for driving 
basic research studies investigating the use of heating as part of cancer treatment strategies. An 
experimentally validated 3D computational model was employed to design and characterize a non-
invasive directional water-cooled microwave hyperthermia applicator for MRI guided delivery of 
hypethermia in small animals. Following a parametric model-based design approach, a reflector 
aperture angle of 120°, S-shaped monopole antenna with 0.6 mm displacement, and a coolant flow 
rate of 150 ml/min were selected as applicator parameters that enable conformal delivery of mild 
hyperthermia to tumors in experimental animals. The system was integrated with real-time high-
field 14.1 T MRI thermometry and feedback control to monitor and maintain target temperature 
elevations in the range of 4 – 5 °C (hypethermic range). 2 - 4 mm diameter targets positioned 1 – 
3 mm from the applicator surface were heated to hyperthermic temperatures, with target coverage 
ratio ranging between 76 - 93 % and 11 – 26 % of non-targeted tissue heated. 
Another contribution of this dissertation is using computational models to determine how 
the fibroids altered ablation profile of a microwave applicator for global endometrial ablation. 
 
 
Uterine fibroids are benign pelvic tumors located within the myometrium or endometrium,and may 
alter the profile of microwave ablation applicators deployed within the uterus for delivering 
endometrial ablation. A 3D computational model was employed to investigate the effect of 1 – 3 
cm diameter uterine fibroids in different locations around the uterine cavity on endometrial 
ablation profiles of microwave exposure with a 915 MHz microwave triangular loop antenna. The 
maximum change in simulated ablation depths due to the presence of fibroids was 1.1 mm. In 
summary, this simulation study suggests that 1 – 3 cm diameter uterine fibroids can be expected 
to have minimal impact on the extent of microwave endometrial ablation patterns achieved with 
the applicator studied in this dissertation.   
Another contribution of this dissertation is the development of a method for experimental 
validation of 3D transient temperature profiles predicted by computational models of MWA. An 
experimental platform was developed integrating custom designed MR-conditional MWA 
applicators for use within the MR environment. This developed platform was employed to conduct 
30 - 50 W, 5 - 10 min MWA experiments in ex vivo tissue. Microwave ablation computational 
models, mimicking the experimental setting in MRI, were implemented using the finite element 
method, and incorporated temperature-dependent changes in tissue physical properties. MRI-
derived Arrhenius thermal damage maps were compared to Model-predicted ablation zone extents 
using the Dice similarity coefficient (DSC). Mean absolute error between MR temperature 
measurements and fiber-optic temperature probes, used to validate the accuracy of MR 
temperature measurements, during heating was in the range of 0.5 – 2.8 °C. The mean DSC 
between model-predicted ablation zones and MRI-derived Arrhenius thermal damage maps for 13 
experimental set-ups was 0.95. When comparing simulated and experimentally (i.e. using MRI) 
 
 
measured temperatures, the mean absolute error (MAE %) relative to maximum temperature 
change was in the range 5 % - 8.5 %.   
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1.1. Overview and motivation 
Thermal therapy is a clinically used treatment modality, which involves modulation of 
tissue temperature for therapeutic effect. Thermal therapy has been used clinically for immediate 
in situ cell death (thermal ablation, [1]), as a minimally-invasive alternative to surgery, treating 
tumors in the liver, kidney, lung, prostate and as an adjuvant therapy (hyperthermia, [2]–[4]) to 
sensitize tumors to chemotherapy and ionizing radiation therapy. Thermal ablation and 
hyperthermia have non-oncological applications as well [5]–[7].  
 During a thermal therapy procedure, the objective is to manipulate the target tissue 
temperature to a specified range, while leaving the surrounding tissue minimally affected. The 
treatment outcome is a function of the intensity and duration of heating within the target tissue. 
Therefore, quantifying the spatial pattern of energy delivered to tissue, and subsequent temperature 
profile, by a thermal therapy applicator is important for predicting the extent of the treatment zone. 
Additionally, it is beneficial to incorporate temperature monitoring capabilities within thermal 
therapy systems to verify that tissue temperature is driven to the desired range relative to the 
desired treatment goal [8]–[11].  
During the development procedure of the thermal therapy systems, to evaluate the energy 
delivery and temperature profiles of the target, device design and biophysical properties of the 
target tissue may be simulated with 3D computational models. Computational models provide an 
approximation of the physical processes during a thermal therapy procedure, and offer the 
advantages of reduced cost and time, for device design and optimization, compared to purely 
experimental driven approaches. These models may be used to explore device design concepts, 
following which the designed device is fabricated and experimentally assessed in ex vivo and in 
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vivo tissue settings. If the outcome of the experiment was not as expected, models may be further 
applied to alter, adapt and optimize the design of the device for the specific goal. The new designed 
device is again fabricated and experimentally assessed.  This iterative process between simulation 
and experiment continues to reach a desirable outcome. Researchers investigate the reliability, 
reproducibility and repeatability of the thermal therapy systems during the development process 
before transition of the system for evaluation in the clinical trial setting.  
Real-time temperature monitoring is of high significance in developing thermal therapy 
systems to locate the heat exposure site and measure the temperature change to prevent irreversible 
damage. To reduce the cost, time and risk of experiment, a thermal therapeutic concept can be 
learned and studied using computational models that are an abstract description of the biological 
and physical system. To ensure the reliability and credibility of the model outputs, verification and 
validation of the model is required. Deep understanding of the challenges a researcher may face 
during implementing each of these components is imperative to ensure the healthcare needs are 
addressed thoroughly, which is the topic of this dissertation.  
1.2. Research approach 
Microwave thermal therapy has been used for a large number of patients and is under 
investigation as a heating modality for oncological and non-oncological applications [12]–[14]. 
The goal of this dissertation is to present new strategies to assist the development of microwave 
thermal therapy systems. Specifically, contributions are focused on the integration of microwave 
ablation and hyperthermia systems with image-guided thermometry in ex vivo and small-animal 
and computational modeling for tissue/application-specific design and characterization. As shown 
in Fig. 1.1, the key elements to accomplish this goal are:  
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(1) Real-time temperature monitoring. During a thermal therapy procedure, energy 
delivery and temperature change may deviate from the anticipated pattern due to tissue 
heterogeneity. Therefore, temperature monitoring is a key factor during thermal therapy to reduce 
the uncertainty and increase the likelihood of delivering thermal profiles within the prescribed 
ranges. A key challenge is to integrate a real-time temperature monitoring technique with the 
energy delivery platform. Magnetic Resonance Imaging (MRI) facilitates non-invasive, real-time 
spatial thermometry for monitoring and guiding thermal therapy procedures [15]. 
(2) Verification and validation of microwave 3D computational models. Computational 
models play an important role in the design and optimization of novel applicators and energy 
delivery strategies [16]. Modeling tools are also under development for treatment planning, to 
guide clinicians in the selection of optimal energy delivery parameters for individual patients, and 
are increasingly important as part of regulatory submissions for characterizing device 
performance. A key challenge with models is the development of established procedures for 
validating model performance. MRI enables non-invasive measurement of spatial temperature 
profiles. Comparing simulated and MR-derived transient temperature profiles facilitates assessing 
the model accuracy. 
(3) Device design and characterization. Researchers use computational models to 
quantify electromagnetic radiation patterns and temperature profiles induced by microwave 
applicators in tissue. New microwave applicator design prototypes are often evaluated using 3D 
computational models and bench-top experiments. A key challenge is characterization and 




Figure 1.1 Workflow for mathematical modeling of microwave thermal therapy for target/application-specific 
design and characterization 
In this dissertation, the following research studies were conducted to contribute to the 
development of microwave thermal therapy technology, while overcoming the challenges relative 
to the three key elements of (1) real-time temperature monitoring, (2) verification and validation 
of microwave 3D computational models and (3) device design and characterization:  
1.2.1. MR-guided localized hyperthermia delivery to small-animal 
Pancreatic cancer is now one of the highest cancer-related cause of death in US [17]. For 
early-stage disease, surgical resection may offer a potential cure,  but 80% of the patients have 
advanced and non-resectable pancreatic tumors at the time of diagnosis [18], [19]. For non-
resectable tumors, pre-clinical studies have shown that sole chemotherapy or in conjunction with 
radiation therapy have impeded tumor growth [20], [21]. Studies have reported that hyperthermia 
sensitizes tumor cells to chemotherapy and decreases chemoresistance for pancreatic cancer cells 
[22], [23]. 
Since tumor models for small animals are widely available, small animals are frequently 
used for pre-clinical experimental evaluation of therapeutic strategies, including thermal 
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treatments [24]. To develop an accurate understanding of the effect of heat on the targeted tumor, 
it is important to verify the thermal doses delivered to the target tissue during hyperthermic 
exposure. Delivering hyperthermic thermal doses to small animals in experimental studies requires 
precise treatment delivery to the target while sparing surrounding tissue and controlling the core 
body temperature [25]. Controlling the target heating volume and conformal heating is a challenge 
for employing microwave energy in hyperthermia treatments. 
Considering all the above, the objective of this research study is to develop small-animal 
MR-guided MW hyperthermia system employing a MW applicator with a localized heating pattern 
(key elements 2 and 3) and controlled energy delivery to the tumor site, relative to its real-time 
temperature change, to maintain tumor temperature in the hyperthermic range (key element 1). 
1.2.2. Sensitivity of ablation microwave applicator to the presence of fibroid 
Menorrhagia, a condition when menstrual periods have abnormally heavy or prolonged 
bleeding, significantly affects quality of life, and affects ~20% of women of reproductive age [26]. 
Surgical interventions, e.g. hysterectomy (to remove the uterus), have been a standard treatment 
when medical therapy fails to mitigate the symptoms. Endometrial ablation is a procedure to 
destroy (ablate) a thin layer of tissue (endometrium) that lines the uterus. It is performed to stop 
or reduce heavy menstrual bleeding. An advantage of endometrial ablation in comparison to 
hysterectomy is that the procedure is that the applicator is introduced via body cavities and no 
incision in the body is required.  
Uterine fibroids are benign lumps that grow on the uterus. Fibroids, may modify the pear 
shape of the uterus, which may affect the endometrial ablation pattern.  
In [27], researchers have previously proposed a microwave applicator for global 
endometrial ablation (GEA) and investigated the feasibility of using a triangular-shaped 
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microwave applicator for GEA in treating uterine cavity of different sizes. The results were 
indicative of a suitable ablation pattern for GEA. However, since women who are candidates for 
endometrial ablation may also have fibroids, it is important to assess the effect of the presence of 
fibroids on the GEA profile.  
Considering all the above, the objective of this work is to investigate the effect of presence 
of fibroids on the endometrial ablation profile employing validated microwave ablation 
computational models (key elements 2 and 3). 
1.2.3. Volumetric assessment of microwave computational models validity using MR 
thermometry 
Computational models play an important role in the design and optimization of novel 
applicator designs and energy delivery strategies [28]–[30]. Modeling tools are also under 
development for treatment planning, to guide clinicians in the selection of optimal energy delivery 
parameters for individual patients, and are increasingly important as part of regulatory submissions 
for characterizing device performance. A key challenge with models is the development of 
established procedures for benchmarking and validating model performance, as well as identifying 
sources of uncertainty. 
For microwave hyperthermia and ablation procedures, the key processes that need to be 
modeled are microwave propagation through tissue, power absorption, and bioheat transfer [31]. 
At elevated temperatures, there are substantial changes in the tissue physical properties – dielectric 
properties [32], [33], thermal properties [34], and blood perfusion [35] – which may have a 
considerable impact on model predictions of treatment outcome [36]. Tissue contraction at 
elevated temperatures is another physical process that may be important to model for accurate 
prediction of ablation zone extents [37]. While temperature dependencies of tissue biophysical 
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parameters have been experimentally measured, experimental validation of microwave tissue 
heating models have been limited. Typically, model-validation is performed by comparing 
simulated transient temperature profiles vs. temperature measured at a few discrete points using 
temperature sensors such as thermocouples or fiberoptic probes [31]–[33]. In addition to the 
limited number of locations (often 2 – 6 sensors are employed) at which temperatures are 
measured, an added source of uncertainty is the position and orientation of the temperature 
measurement probes relative to the microwave heating device under test. 
Considering all the above, the objective of this study is to develop an experimental platform 
providing temperature measurements at a multitude of locations to enable more comprehensive 
verification and validation of computational models of microwave tissue heating (key elements 1 
and 2). 
1.3. Contributions 
This dissertation contributes to research work carried out to address the challenges and 
questions of the case studies mentioned in section 1.2.   
Contribution 1: Hyperthermia is a clinically proven sensitizer for ionizing radiation 
therapy, and is under investigation for thermally-mediated release of cancer therapeutic agents 
[38]. Due to heterogeneity in tissue biophysical properties and blood perfusion profiles, a given 
set of energy delivery parameters may yield highly variable thermal profiles in vivo. MRI affords 
noninvasive temperature monitoring with the Proton Resonance Frequency Shift technique, 
thereby providing a means to ensure adequate delivery of prescribed thermal doses [39]. Compared 
to existing small-animal systems for hyperthermia delivery, ultra-high field 14.1 T MRI offers the 
advantages of high temporal and spatial resolution for a pre-clinical platform for delivering 
hyperthermia to experimental small animals. MRI-derived temperature profiles during 
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hyperthermia, can be used to adjust applied power in order to achieve the desired thermal dose. 
We have designed an experimental platform for hyperthermia investigations in small animals, 
incorporating a microwave applicator integrated with 14.1 T ultra-high field MRI. We adapted the 
applicator design, to focus heating within 0.0141- 0.113 cm3 tumor volume located at 1-3 mm 
from the skin surface, with minimal heating of the surrounding tissue. The developed platform was 
applied in pilot studies to assess the biophysical effects of mild heating on implanted pancreaticc 
tumors in small-animals. This contribution is discussed in detail in chapter 3 and in the following 
publications: 
[40] P. Faridi, S. H. Bossmann, and P. Prakash, “Simulation-based design and 
characterization of a microwave applicator for MR-guided hyperthermia experimental studies in 
small animals,” Biomed. Phys. Eng. Express, vol. 6, no. 1, p. 015001, Nov. 2019. 
[41] S. Curto, P. Faridi, T. B. Shrestha, M. Pyle, L. Maurmann, D. Troyer, S. H. Bossmann, 
and P. Prakash, “An integrated platform for small-animal hyperthermia investigations under ultra-
high-field MRI guidance,” Int. J. Hyperth. Off. J. Eur. Soc. Hyperthermic Oncol. North Am. 
Hyperth. Group, vol. 34, no. 4, pp. 341–351, 2018. 
Contribution 2: Uterine fibroids are benign lumps that grow on the uterus and modify the 
shape of the uterus, which may affect the endometrial ablation pattern. In this research, we have 
investigated the effect of presence of fibroids on the endometrial ablation profile. First, we have 
experimentally validated 3D computational model of global endometrial microwave applicator in 
ex vivo liver tissue. Next, the validated computational models were employed incorporating 
fibroids in variant sizes and locations mimicking real conditions of women uterus. This study 
served as a pre-clinical approach to investigate the effect of fibroids on the ablation profile of the 
GEA loop MW antenna to increase safety and identify, assess and measure risks of using this 
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specific antenna before translating to clinical trials. Details of this study is discussed in chapter 4 
and in the following publications: 
[42] P. Faridi, H. Fallahi, and P. Prakash, “Evaluation of the Effect of Uterine Fibroids on 
Microwave Endometrial Ablation Profiles,” in 40th Annual International Conference of the IEEE 
Engineering in Medicine and Biology Society (EMBC), Jul. 2018, pp. 3236–3239. 
Contribution 3: Microwave ablation is increasingly being used for image-guided ablation 
of tumors in the liver, lung, and other sites. Computational models that predict ablation outcome 
for specified applied energy levels are invaluable for guiding the design of ablation devices; 
comparative assessment of treatment delivery strategies; device characterization for regulatory 
submissions; and are under development for patient-specific treatment planning. Current 
approaches for validation of microwave ablation models have been limited to comparing simulated 
and experimental measurements of ablation zones at a few discrete points, as well as comparing 
experimentally observed ablation profiles with simulations. Here, we have developed a microwave 
ablation platform integrated with 3T MRI, providing a means for comparative assessment of 
model-predicted and measured 3D temperature and ablation profiles. This study reports paves the 
way for further investigation of models for application in pre-treatment planning of MWA ablation 
procedures. Details of this study is discussed in chapter 5 and in the following publications: 
[43] Faridi, P. and Prakash, P., (2018). Experimental validation of computational models 
of microwave tissue heating with magnetic resonance thermometry, IEEE International 
Microwave Symposium (IMS), Philadelphia, PA. 
[44] P. Faridi, P. Keselman, H. Fallahi, and P. Prakash, “Experimental assessment of 
microwave ablation computational modeling with MR thermometry,” Med. Phys., 2020. 
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1.4. Dissertation outline 
This dissertation is organized as follows. The second chapter is dedicated to a brief 
introduction of image-guided thermal therapies for cancer treatments. Chapters 3, 4 and 5 report 
on the research topics introduced in sections 1.2.1 – 1.2.3. The final chapter presents concluding 






Extensive investigations of the biological effects of therapeutic heating has led to clinical 
translation of technologies for treatment of cancer. Several clinical trials have demonstrated the 
benefits of mild hyperthermia, moderate heating in the range of 39 < T < 45 °C for 20-60 mins, as 
an adjuvant to ionizing radiation and chemotherapy of select cancers [46]–[48]. Thermal ablation, 
heating to temperatures in excess of 50 °C, is increasingly being used for treatment of surgically 
unresectable tumors in the liver, kidney, lung, and other organs [49].  
Fig. 2.1 illustrates the components of a generic image-guided thermal therapy system. 
Minimally/non-invasive applicators deliver therapeutic energy from an external source to the 
targeted tissue. Real-time imaging facilitates accurate positioning of the applicators relative to the 
targeted tumors, to maximize the likelihood of delivering safe and effective treatments. Imaging 
data may also serve as input to simulation-based predictive models that assist physicians in 
selecting energy delivery parameters tailored for individual patient anatomies. Techniques for 
measuring spatial temperature profiles in the targeted tissue provide a means for real-time 
monitoring of treatment progress, which is particularly important because unknown blood 
perfusion profiles serve as a heat sink, and may yield highly variable thermal dose profiles for a 
fixed set of energy delivery parameters. These can be coupled with feedback-control techniques 
to afford conformal delivery of prescribed thermal doses on a patient-specific basis. This report 
will detail the technical foundations of each of the components summarized in Fig. 2.1. 
                                                 





Figure 2.1 Overview of thermal therapy systems 
 
2.2. Biological Rationale for Thermal Therapy 
2.2.1.  Review of Physiological Effects of Heating and Thermal Dosimetry 
Fig. 2.2 summarizes the physiological effects of heating over the temperature range 37 – 
100 °C. Mild heating at temperatures in the range of 37-43 °C yields increases in local blood flow. 
The response of vasculature to heating differs in healthy and tumor tissues, yielding biophysical 
effects that can be targeted for therapeutic applications. Normal tissues have more structured 
vasculature compared to tumors, resulting in greater convective heat loss during heating. 
Furthermore,  vessels in healthy tissue dilate in response to heating, thereby increasing blood flow 
rate which in turn leads to greater heat dissipation, temperature alleviation, and lower damage to 
normal tissues comparing tumors [50]. Consequently, exposure to a fixed amount of therapeutic 
energy may yield increased heating in tumors relative to healthy tissue. Thermosensitivity of 
tumors is also influenced by hypoxic cancer cells and the acidic tumor microenvironment. Low 
pH reduces blood flow rate which in turn leads to lower amount of oxygen delivery to the tumor 
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cells. At higher temperatures, in excess of 45 °C , blood flow rate decreases causing  thrombosis, 
heat trapping and tissue necrosis [51]. 
Thermotolerance, impediment to thermal cytotoxicity, is regulated by the release of Heat 
Shock Protein (HSP). HSPs are chaperone proteins which are upregulated during heat stress, and 
transport misfolded proteins to the cell membrane. [52]. However, this phenomenon occurs only 
up to approximately 43-43.5 °C [53]. 
 
Figure 2.2 Physiological changes induced by heating 
Thermal damage induced by heating is a function of the time-temperature history during 
heating. Fig. 2.3 illustrates an Arrhenius plot for Chinese Hamster Ovary (CHO) cells exposed to 
isothermal heating at various temperatures. In Figure 2.3, D0 defines the time at a particular 
temperature for cells to reach the 63% survival rate. Cellular deactivation due to heating can be 
calculated using Equation (1): 
  
( / )E RTB Ae −=  (1) 
 
where B is the rate constant (B = 1/D0), E is the activation energy [kcal/mole], R is the 
universal gas constant, A is the frequency factor, and T is temperature in K. A clear breakpoint in 




Figure 2.3 Arrhenius plot for CHO cells  (Arrhenius coefficients for generating this plot are taken from Reference 
[54]) 
Sapareto and Dewey developed a thermal isoeffective dose model for comparing non-
isothermal exposures to an equivalent isothermal exposure at a reference temperature. 43 °C is 
typically taken as the reference temperature due to the breakpoint in deactivation at this 















where CEM43 is the cumulative equivalent minutes at 43 °C, R represents the rate of 
damage below and above break point, and T stands for the measured temperature during heat 
exposure. For most cells, at temperatures below 43 °C, R = 0.25; at temperatures greater than 43 
°C, R = 0.5. This thermal dose model has found widespread applications in research and clinical 
studies for comparative assessment of the effects of therapeutic hyperthermia exposures [55].  
2.2.2. Moderate heating/ Hyperthermia 
Moderate heating in the range of 40-45 °C for 20 to 90 minutes has the following effects: 
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2.2.2.1 Mild cytotoxicity. 
Heating in the range of 40- 45 °C for 20-90 min has a cytotoxic effect on tumor cells. While 
early clinical applications of hyperthermia aimed to achieve cell kill via heating, this proved to be 
ineffective due to the technical challenges of maintain tumor temperatures within the desired 
change in the absence of real-time volumetric thermometry.  
2.2.2.2 Increased Efficacy of Chemotherapy and/or Ionizing Radiation.  
In addition to cytotoxic effects, heating at temperatures in the range of 40-45 °C synergizes 
with chemotherapy and ionizing radiation therapy. Large tumors have reduced blood flow 
compared to healthy tissues due to the disordered vasculature structure. Consequently, the effect 
of chemotherapy in large tumors is hampered, because the poor blood flow limits the amount of 
drug delivered to the tumor. During hyperthermia, physiological changes such as higher blood 
flow rates and higher vascular permeability due to increased vessel pore size, result in enhanced 
delivery of chemotherapeutic drugs [56]. Furthermore, increased blood flow also alleviates 
hypoxia in large tumors, which increases the efficacy of ionizing radiation therapy. Radiation 
therapy takes advantage of reoxygenation of the hypoxic tumor environment because molecular 
Oxygen (O2) possesses a high potential for radio-sensitization [57]–[61]. Mild temperature 
hyperthermia also influences a part of cell cycle which is resistant to radiation (i.e, the S- phase) 
[62].   
2.2.2.3 Stimulation of the immune response. 
Tumor cells possess antigens that are recognizable by the immune system [63]. 
Hyperthermia navigates a high range of these unique antigens to the tumor surface, thus enhancing 
the performance of the immune system response to tumors [64]. Moreover, hyperthermia initiates 
a negative feedback response with the induction of HSPs on the tumor site during heat exposure, 
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which magnifies the immune response [65]. HSPs activate Dendritic Cells (DCs) which are 
antigen-restricted, do not recognize normal cells, thereby inhibiting collateral damage to normal 
cells [63]. Additionally, hyperthermia modifies blood flow in tumor sites which in turn facilitates 
a higher rate of immune cells transmission to the tumor. The specific time temperature ranges 
within immune stimulation is observed remains the subject of active research [66]. 
2.2.3. Tumor Ablation 
Thermal tumor ablation refers to the destruction of tumors by exposing tumor tissue to T 
> 50 °C for 10-15 minutes. Cell death at temperatures in excess of ~60 °C occurs within a few 
seconds. Several energy modalities have been applied for thermal ablation, including: 
radiofrequency current, microwaves, lasers, and ultrasound. Cryoablation refers to tissue freezing 
which has been clinically applied for tumor ablation. Non-thermal techniques for thermal ablation, 
such as irreversible electroporation have also been developed.  
During an ablation procedure, a minimally invasive applicator (typically, less than 2.5 mm 
in diameter) is inserted into the target tumor under image guidance. Energy delivered by the device 
is absorbed by surrounding tissue leading to heating. In proximity to the ablation device, the 
majority of heating is due to direct power absorption from the energy source. Due to steep thermal 
gradients, heat spreads radially outward from the ablation applicator, leading to enhancement of 
the ablation zone by passive thermal conduction.  
As illustrated in Fig. 2.4, the ablation zone can be divided into three sub-sections around 
the applicator, each displaying a variety of physiological changes based on the extent of tissue 
heating. In the central zone, tissue in closest contact with the ablation device, necrosis is the 
dominant feature. Tissue in the central zone is in excess of 50 °C, and peak temperatures could be 
greater than 100 °C depending on the energy modality used. In the transition zone, tissue 
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temperature is in the range of 42-47 °C; in this region, passive heat transfer due to thermal 
conduction is the major source of heating. Apoptosis and some forms of sublethal thermal damage 
are observed in the transition zone. Beyond the transition zone, the tissue temperature in the mild 
hyperthermia zone ranges from 39-42 °C [49], [67]. 
 
Figure 2.4 Sub sections of ablation zone, A) central zone, B) transitional zone, C) mild hyperthermia zone [68] 
2.2.4. Thermally-triggered Release of Therapeutic Agents 
There are significant barriers obstructing drug delivery to cancer cells which limits the 
specificity of chemotherapy [69]. To alleviate this problem, therapeutic agents may be transported 
and delivered through carriers such as polymers, liposomes and particles. Using drug delivery 
systems employing carriers in conjunction with heat exposure, has led to improvement in 
increasing the quantity of drug delivered to tumor.  
Polymers, macromolecular carriers, are biocompatible materials used for delivering 
chemotherapeutic agents to the target. Responsive-polymers are a specific type of polymer that 
respond to external stimuli (physical or chemical). One class of polymers, referred to as 
thermosensitive polymers, undergo a phase transition at a critical temperature. Using heat as a 
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trigger for responsive polymers permits the use of hyperthermia for localized drug release [70]. 
Temperature sensitive responsive polymers are subjected to phase transition based on distinctively 
selected temperature threshold according to the drug delivery system. Hydrophilic structure of 
responsive polymer is activated below its lower critical solution temperature (LCST) where it 
remains in acqueous solution; however, above LCST it collapses and releases therapeutic agents. 
A typical critical temperature in the range of 39-40 °C as this value is above normothermic 
temperature, and at the same time, lower than hyperthermic temperatures where vascular stasis 
occurs, thereby limiting drug release within the heated target [71].  
Liposomes for drug delivery are vesicles containing a bilayer lipid surrounding aqueous 
solution which establishes the context of injecting and transporting hydrophilic and hydrophobic 
therapeutic drugs at the same time. Temperature sensitive liposomes (TSLs) exploit the 
contribution of hyperthermia in conjunction with liposomal drug delivery to transport, aggregate 
and preserve chemotherapeutic agents. TSLs are triggered above a temperature threshold, which 
is associated with temperature change during hyperthermia procedure, to decrease the possibility 
of drug extravasation into healthy cells. Fig. 2.5 illustrates the temperature dependent structure of 
TSLs [72].  
 
Figure 2.5 Liposomal drug release during hyperthermia (HT) in tumors.At temperatures in the range of 41-44 °C, 
drug is released from temperature sensitive liposomes (TSL) within the vasculature. Extravasation is enhanced by 







2.2.5. Methods of Tissue Heating 
2.2.5.1 Microwave Tissue Heating 
Microwaves, electromagnetic waves with frequency ranging between 30 MHz – 300 GHz 
have been widely used for thermal therapy (both hyperthermia and thermal ablation). Polar 
molecules in tissue, such as water and protein, attempt to align with the polarity of the electric 
field, leading to heating by dielectric hysteresis (see Fig. 2.6) [73]. 
 
Figure 2.6 Schematic illustration of the interaction between water molecules and microwaves. (adapted from [28]) 
Microwave propagation and absorption within tissue is governed by the complex dielectric 
properties of tissue 𝜀(𝜔) =  𝜀′(𝜔) − 𝜀′′(𝑗𝜔), where 𝜔 is angular frequency. The real part, 𝜀′(𝜔),  
is a measure of a material’s ability to store the electric field, while the imaginary part, 𝜀′′(𝑗𝜔), is 
a measure of loss. The effective electrical conductivity is given by 𝜎𝑒𝑓𝑓 = 𝜎𝑠 + 𝜔𝜀
′′. Frequency 
dependent dielectric properties for a range of tissue types have been measured by several groups 
and reviewed in [74], [75]. From these fundamental properties, the absorption coefficient alpha 
can be computed using: 
 















The penetration depth, d [m], is defined as the reciprocal of the attenuation coefficient and 
is a measure of the distance within a material which a wave propagates before it is attenuated to 
1/e (i.e. 36.8%) of its original intensity.   
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Electromagnetic penetration depth, d, decreases with increasing frequency. Thus, lower 
frequencies are better suited for non-invasive energy delivery to deep-seated tissues. However, 
smaller wavelengths at higher frequencies facilitate the use of smaller antennas and ability to focus 
power deposition patterns to smaller regions. The choice of operating frequency for specific 
applications trades off these two considerations.  
 Microwave hyperthermia systems 
Microwave thermal therapy systems consist of a high power signal source, power delivery 
cables, and microwave antennas that radiate energy to the target tissue. For hyperthermia, non-
invasive applicators operating at 100-400 MHz have been developed for regional heating of pelvic 
[76], limb [77], and head-and-neck targets. At these frequencies, wavelengths are relatively long, 
leading to large focal spots, with limited precision of heating [78].  A challenge with non-invasive 
delivery is the unintended heating (“hot spots”) due to dielectric differences at tissue interfaces.  
Several microwave applicator designs have been presented in the literature and are in 
clinical use for hyperthermia and tumor ablation [78]. Microwave hyperthermia applicators are 
under development for pre-clinical small animal investigations [79]–[83]. A simulation based 
water loaded microwave applicator with operation frequency of 2.45 GHz was designed, optimized 
and implemented in [83] for murine bladder hyperthermia in combination with chemotherapy. The 
microwave applicator is adjustable for volume and depth of heating. In vivo studies shown that it 
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can heat small tumors to the hyperthermic range with 2-3 mm depth from the body skin. In this 
study, temperature was monitored subcutaneously, in vagina and rectum with 3 fiber optic probes 
connected to a motor that pulled them out every 1 mm for 15 levels and push them inside again 
for 15mm to reach the initial place. Given the real time temperature measurements, manual 
feedback control was applied to change the input power to keep the temperature constant in the 
hyperthermic range. Bladder temperature was assumed 1-2 °C higher than vagina temperature 
according to their in vitro validated numerical model.  
 Systems and devices for microwave ablation have evolved from those originally 
developed for hyperthermia, as recently reviewed by Ryan et al. [84].   
 Microwave ablation systems 
Microwave ablation devices are thin cylindrical antennas, attached to a microwave 
generator to produce adequate amount of power at a certain frequency; 915 and 2450 MHz are 
most widely used in clinical systems, though higher frequency systems are under investigation 
[85], [86]. Early devices consisted of coaxial-based antennas. Recent developments include 
modified microwave devices to overcome the challenges with unintended heating along the 
applicator feedline. For instance, sleeves/chokes antennas are designed to control the heating along 
the antenna shaft [87]–[90]. Active cooling along the antenna shaft limits unintended heating to 
adjacent tissue due to losses within coaxial cables [7]–[9].  
 
Figure 2.7 Example clinical microwave ablation system, Evident TM Microwave ablation system/Covidien Ltd, (a) 




Figure 2.8 Example of a 2.45 GHz cooled-shaft microwave ablation device from Nanjing Yigao Microwave Electric 
Institute, Nanjing, China. The black arrow displays the radiation section of the applicator. The microwave generator 
is connected to applicator via the connector indicated with the white arrow. (Image reproduced with permission from 
Zhou W et al., (2013) Comparison of ablation zones among different tissue using 2450-MHz cooled-shaft microwave 
antenna: results in ex vivo porcine models. PLOS One 8(8): e71873. doi: 10.1371/journal.pone.0071873 [94]) 
2.2.5.2 Radiofrequency Current 
RF energy for tissue heating is delivered via electrodes inserted to the tissue, whether 
percutaneously or during open surgery. RF ablation typically employs currents operating at 460-
500 kHz [95], [96]. The mechanism of heating during RF ablation is due to the agitation, oscillation 
and collision of ions within tissue. The peripheral ablation area is created due to thermal 
conduction in the surrounding tissue which is as small as few millimeters [73]. 
Limitations of RF ablation include: relatively small region of active heating within ablation 
zones, necessity of ancillary components such as grounding pads, and tissue electrical impedance 
limitation due to water vaporization when temperature increases up to 100 °C that impedes further 
electricity deposition. The latter effect is highly enunciated if charring has occurred and insulated 
the electrodes [97].  
RF applicators can be used for either bloodless superficial incision such as skin tumors, 
lesions in bladder or gastrointestinal which are accessible via body cavities [98] or deep-seated 





Figure 2.9 Various commercially available RF devices, (a) RITA 14G Starburst XL needle, (b) Cooled-tip Radionics 
needle, (c) LeVeen pronged needle and (d) The Berchtold needle with holes at the end of the needle (Image reproduced 
with permission of Springer from European Radiology, Radio-frequency tissue ablation of the liver: in vivo and ex 
vivo experiments with four different systems, vol. 13, 2003, 2346-52, A. L. Denys et al. [100]) 
 
2.2.5.3 Lasers 
Laser-tissue interaction is based on the physical mechanism of photon penetration, absorption, 
and scattering in tissue. Absorption occurs via electron excitation and transmission to a higher 
state. Chromophores are the light absorbing component of the tissue that converts the laser beam 
to thermal energy by absorbing the water within the lasers path. Penetration depth reduces rapidly 
with increased water content [101]. Absorption coefficient, µa, is defined the same as scattering 
coefficient. The penetration depth of laser within tissue is given by 1/ µa. The total energy 
attenuation coefficient µt, is defined in Equation (5): 
     µt = µs + µa     (5) 
The higher absorptive capacity of the tissue compared to scattering ability results in keeping the 
energy in line with laser beam diameter. Greater scattering capacity diffuses the energy outside the 
beam light diameter [102].Taking into account all the above laser principles and optical 
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characteristics, µs, µa and g, several reactions occur relevant to medical applications: chemical, 
thermal reactions, tissue ablation and photodisruption [103]. 
In addition to interstitial tumor ablation, laser thermal therapy has applications in dermatology 
and ophthalmology [104]. Laser is either transmitted to the target through optical fiber 
noninvasively or inserted invasively to the target and produce thermal ablation through its inserted 
tip into the tissue. One of the applications of interstitial laser ablation is focal heating and image 
guided drug delivery (IGDD) as shown in Fig. 2.10. Laser systems have been integrated with MRI 
thermometry for providing real-time assessment of target heating, and to avoid lethal damage to 
healthy tissue while affording drug delivered to the target and temperature profile during the 
experiment.  
 
Figure 2.10 MR compatible laser applicator used for thermal ablation and drug delivery. Nanoparticles carrying 
drugs are exploded during treatment releasing drugs within the tumor (Image reproduced with permission of 
Springer from Pharmaceutical Research, MRI-guided monitoring of thermal dose and targeted drug delivery for 
cancer therapy, vol. 30, 2013, 2709-17, R. Fernando et al. [105]) 
Fig. 2.11 shows an example laser device, in clinical use for thermal ablation, incorporating a 
cooling catheter to restrict peak tissue temperatures within surrounding tissue and reduce the risk 
of applicator damage.  
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The size of ablation zones achievable with lasers is limited (~1-2 cm) because of the rapid 
absorption and scattering features of tissue small ablation zones. These ablation zone sizes are 
relatively small compared to the other energy modalities described previously [104].  
  
Figure 2.11 Laser induced thermal therapy (LITT) device, (a) An illuminated fiber tip and shaft covered with 
magnetite particles for visibility during MR Imaging, (b) Visualase laser device with cooling shaft. (Image 
reproduced from [106]) 
2.2.5.4 Ultrasound 
Ultrasound (US) is a mechanical pressure wave, with frequency in the range 20 kHz – 10 
MHz, causing 3D molecular oscillation around their mean position in the direction of wave 
propagation.  Ultrasound propagates through the tissue which attenuates exponentially as energy 
moves away from the source. The energy amplitude, acoustic intensity, is the time average of 
energy flow through a unit area. In general, US waves are transmitted from a transducer, made 
from piezoelectric crystals which vibrate in response to the applied input voltage thereby 
generating high frequency sound pressure waves, focused in a desirable spot with diameter less 
than applicator diameter at a distance of 5-20 times larger than the applicator diameter (Fig. 2. 12) 
[107]. 
US can be used for either hyperthermia with long time heat exposures and low temperature 
rise to sensitize tissue to radiotherapy/ chemotherapy as discussed in section 1, or ablation with 
low time duration of experiment and great temperature rise. When temperature increases to 100 
°C, tissue water evaporates and changes its state to gas. US energy interaction with gas bubbles 
26 
 
inside the tissue significantly differs from liquid water molecules, due to different density and 
sound speed, and, therefore, temperature distribution is modified based on higher rate of reflection 
and scattered beams in the gas bubbles. High pressure ultrasound produces microbubbles, in a 
process called acoustic cavitation. Inertial cavitation is a phenomenon caused by microbubbles 
explosion due to high amplitude pressure and consecutively expansion and contraction of 
microbubbles, which results in mechanical tissue destruction [107].  
 
 
Figure 2.12 (a) Illustration of beam path and focal spot from a curved ultrasound transducer (illustration adapted from 
[107]). 
 
High intensity focused ultrasound (HIFU) ablates the tumor based on two strategies; (a) 
thermal effect and (b) mechanical effect. Thermal effect of US allows the tissue to absorb the 
energy, convert to heat leading to coagulative necrosis while mechanical effect is manufactured 
with mechanical force and displacement of US transducer such that it creates an acoustic cavitation 
[108]. High frequency mechanical acoustic waves delivered to the localized target causes tissue 
dilution leading to periodic elevation and alleviation of tissue pressure. As a consequence of 
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alternative changes in tissue pressure, gas bubbles are created inside tissue which can interact with 
US waves to eradicate tumor cells via necrosis. A clinical HIFU system is shown in Fig. 2. 13.  
 
Figure 2.13 JC HIFU system used for monitoring and therapeutic systems (HAIFU Technology Company, 
Chongqing, PR China) (Image reproduced with permission from reference [109]). 
Single element HIFU systems may not be capable of heating the large regions of interest 
and requires mechanical steering of the beam to treat the entire target region. This displacement 
may cause heterogeneous temperature distribution and is a time consuming procedure [105]. To 
overcome these challenges, phased array transducers are employed allowing electronically steering 
of the ultrasound beam, by applying a time delay or change in phase angle to the signal exciting 
each transducer, such that an optimized amount of energy is projected to the desired spot. Phased 
array transducers enabling heating of the target with varying beam shapes and sizes, adjustable 
focal point size and position to avoid discontinuities between the focused points of all the 
transducers. Phased array transducers may perform with phase difference to focus on a single focal 
spot, or may possess multiple focal points to heat up a larger area at the same time to reduce the 
treatment time [107], [110]–[113]. As such, phased array transducers provide strong flexibility for 
adjusting focal spot size, shape, and location, to minimize unintended heating of non-targeted 
tissues   [114].  
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Although thermal HIFU has been investigated for more than a decade, mechanical HIFU 
is still under development [10] and the corresponding physiological changes occurring during 
HIFU ablation are still not well understood [115], [116]. HIFU integration with monitoring 
techniques such as magnetic resonance imaging (MRI) is recognized as a platform for 
hyperthermia experiments due to its capability of maintaining temperature constant [117]. 
2.2.6. Image Guidance and Monitoring for Thermal Therapies 
2.2.6.1 Significance of Image Guidance 
Thermal therapy regimes target tumor sites with negligible damage to healthy tissue. 
During a thermal therapy procedure, biological and physiological changes in the tissue, accurate 
heat localizing and the amount of thermal dose delivered to the tissue are not well determined due 
to heterogeneity in tissue physical properties. One of the most significant changes is the blood 
perfusion which functions differently based on tissue architecture. In order to verify the amount of 
thermal dose delivery to the treated target and to evaluate the performance of the procedure, real 
time monitoring and image guidance is of high importance. Image guidance improves the accuracy 
of thermometry, provides a thermal map to validate the precise thermal tissue targeting and offers 
the therapeutic system the ability to control the amount of heat delivery to the tumor site while 
sparing the surrounding tissue. 
2.2.6.2 Techniques for Monitoring Treatment Progression 
Noninvasive thermal dose monitoring techniques are utilized with integration to heating 
modalities to acquire thermal map, for real time monitoring and treatment guidance. These imaging 




 MR Thermometry 
Magnetic Resonance Imaging (MRI) is one of the most prevalent, reliable and 
comprehensive thermal monitoring methods to measure temperature profiles inside the tissue 
along with illustrating anatomical information. MR images consists of two sets of data; Magnitude 
Imaging monitors anatomic information such that different organs, tumor site and the location and 
direction of thermal applicator. Phase Imaging provides a relative measurement of temperature 
change with the proton resonance frequency shift (PRFS) method [83], [84].  
Using PRFS method, temperature change can be measured by way of phase changes 
occurring during imaging due to PRFS temperature dependent parameters. Frequency of water 
protons are sensitive to temperature change and can be expressed as [118], [119]: 
  𝑓𝑤𝑎𝑡𝑒𝑟 = 𝛾(1 + 𝜎𝑇 + 𝜎0)𝐵0  (5) 
 
where B0 is the MR static magnetic field, γ is the gyromagnetic ratio and σT  and σ0 are 
local magnetic susceptibilities caused by temperature and non-temperature components. In water-
rich organs (not lipids), σ0 is negligible and the changes in the proton frequency are due to 
temperature changes in tissue caused by thermal treatment [120]. The frequency changes can be 
written as: 
  𝜎𝑇 = 𝛼. Δ𝑇 (6) 
  Δ𝑓 = 𝛾𝛼Δ𝑇𝐵0 (7) 
 
where α is temperature dependent coefficient (°C/ppm). For a given echo time (TE) defined in the 
imaging sequences, phase difference is converted to temperature changes as described in Equation 
(8): 
 








where each phase image during heating experiment, φ(T), is subtracted from the initial phase 
image which contains a specified temperature information, φ(T0) so that the phase change becomes 
proportional to temperature change.  
Fig. 2.14 demonstrate MRI images of a phantom and live mouse derived from a 14 T 
vertical scanner (Bruker Ascend III, 30 mm diameter micro-imaging probe).  
 
Figure 2.14 (A) Photograph of a vertical MRI scanner, (B) in vivo anatomical image of mouse, (C) tissue-mimicking 
phantom, a and b are fiber optic temperature probes inserted inside the phantom to validate the temperature 
measurement with PRFS method and c shows the heating applicator  
MRI guided thermal therapy provides a noninvasive temperature monitoring method which 
can be integrated with different heating modalities to improve the accuracy of treatment. As shown 
in figure above, MR can locate tumor site, heating applicator position and direction along with 
monitoring spatio-temporal temperature map to limit healthy tissue damage. Figure 2.15 shows 
MR temperature map during breast cancer ablation using MR guided focused ultrasound 





Figure 2.15 Temperature superimposition on MR magnitude images of breast cancer using HIFU with temporal 
resolution of 2.5 s, (a)-(d) display the coronal and (e)-(h) display the sagittal images [121]) 
 
Figure 2.16 In vivo RF ablation on the liver of pig, (a) MR temperature overlay on the anatomic image after 330 s, 
(b) Thermal dose map after 970 s at the end of treatment showing thermal damage reached tissue surrounding the RF 
applicator, (c) Macroscopic image of ablation zone after liver fixation in which diameter of the ablated zone (white 
and red arrows) is measured perpendicular to RF applicator, (d) Temperature change during thermal ablation, input 
power is demonstrated in gray, black dashed and dotted lines indicate the temporal evolution of temperature in 10 mm 
and 40 mm away from the applicator which is illustrated in dashed white line (Image reproduced with permission of 
Springer from European Radiology, Real time monitoring of radiofrequency ablation based on MR thermometry and 
thermal dose, vol. 18, 2008, 408-16, O. Seror et al. [122]) 
A major drawback of PRF phase mapping method is sensitivity to motion inside the MR 
scanner. For in vivo procedures, movement of the rodent inside the device while scanning causes 
motion artifacts such as blurring and ghosting in anatomical images and also, it’s an impediment 
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for temperature measurements [123]. According to equation 6, the subtraction of phase images is 
proportional to temperature change, however, movement of the object alters the position of specific 
area in each image with respect to the baseline image. Therefore, to circumvent this problem, 
different methods such as referenceless and multi-baseline method have been investigated [124]–
[126]. 
 US thermometry 
Sound waves transmitted to organs inside the body by piezoelectric transducers are 
partially reflected due to the variety of tissues and organs density. The high frequency reflected 
beam waves are detected by piezoelectric transducer, converted to electric signals with different 
strength carrying anatomical information and thus constructing US images. 
The goal of US imaging guidance, the same as other imaging techniques, is to localize the 
tumor site and its boundaries inside the organs. US imaging may not be repeatable due to its 
operator dependency in finding the target tumor, inconsistency and artifacts caused by bone and 
air interaction with US beams that decrease the quality of imaging. US is better defined for imaging 
superficial soft tissue. In comparison to MRI images and MRI-HIFU guidance, organs and 
abnormal tissues visualization is of lower spatial and temporal resolution with US and also, US is 
not capable of measuring temperature change [107]. However, some developments exist that 
improves the US thermometry for guiding HIFU ablation monitoring [127], [128].      
Besides all the weaknesses of US compared to MR treatment guidance discussed above, 
US imaging hast its own merits and strengths. US is an available, small and inexpensive device. 
Because of its real time monitoring ability, the whole tumor treatment procedure can be visualized 
along with a variety of changes that occurs in tumor, marginal tissues and also blood flow. 
Although, sometimes tumor disappears during treatment when temperature increases. US 
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thermometry employs different image acquisition geometries including passive, pulse-echo, and 
hybrid which are briefly described below [129].  
In passive geometry, thermal strain and cavitation are influenced by temperature change 
dependent characteristics including speed of sound and beam attenuation, leading to the ability of 
ablation temperature monitoring. A diagnostic transducer receives the acoustic beams emitted 
from the HIFU treated ablation zone [129]. In some cases, the beam generating transducer, the 
active transducer, and the diagnostic one, passive transducer, are the same [130].  
As for pulse-echo imaging, same transducer is utilized for generating and receiving signals. 
During the pulse-tissue interaction, temperature dependent parameters may be altered and produce 
some acoustic echoes which can be used for temperature estimation. In both of the above 
geometries, single or array elements can be used for monitoring. Array elements can monitor a 
wider range of tissue [129].  
Hybrid method combines ultrasonic imaging with an alternative imaging modality to 
improve the performance of thermometry. Photoacoustic is of great interest which uses US images 
with high spatial resolution and low contrast combined with optical imaging with reciprocal 
features where the inner chromophores result in high contrast image. In summary, optical laser 
produces a sharp with low bandwidth pulse, leading to temperature distribution and elevation and 
consequently, generating acoustic waves. These acoustic waves are received by diagnostic 
transducer, generating photoacoustic images [129].  
 CT Thermometry 
As with US and MR thermometry, computed tomography (CT) scans possess a CT number 
which is temperature dependent allowing the noninvasive X-ray CT scan to provide thermal map 
during thermal therapy procedures. A major drawback of CT compared to MRI-based thermometry 
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is the patient exposure to radiation for acquiring CT scans. However, CT scans are available at 
lower costs compared to MRI scanners. CT number is a function of the density of the treated tissue 
which in turn changes with temperature modification [131]. During thermal therapy, temperature 
of target region increases leading to tissue expansion and density reduction. Fig. 2. 17 reports the 
dependency of CT scans on the temperature.  
 
Figure 2.17 The dependency of CT value on temperature (illustration adapted from reference [131]) 
 
2.2.7. Feedback Control Techniques 
As for the different strategies of thermal therapy, the amount of temperature change and 
blood flow rate differ. Thermotherapy procedure cannot follow the same heating and therapy 
pattern due to different tissue properties in each individual, unknown fluctuations of blood 
perfusion and undefined disturbance. The need for adjusting the thermal dose and keep track of 
temperature change necessitates using a feedback control, particularly during long time heat 
exposure such as mild hyperthermia experiments. In order to reach the desired treatment plan 
during the practical experiments, temperature dependent tissue properties, blood perfusion rate, 
post treatment thermal effects while limiting thermal damage to healthy tissues should be 




Target temperature during thermal therapy is locally monitored either invasively inserting 
temperature sensors measuring temperature in specific spots [132], [133] or non-invasively 
utilizing imaging modalities providing spatial temperature map.    
Real time monitoring is a prerequisite for non-invasive feedback control. By way of real 
time monitoring, thermal dose delivering to the correct region is displayed and, consequently, 
feedback control can be adjusted to keep the experiment parameters in line with the experiment 
goal. Feedback controlled closed loop system can be designed based on the temperature and heat 
energy distribution and thermal zone estimation [134]–[138]. Controllers such as PI [138], [139], 
PID, multipoint adaptive control [140] and linear quadratic regulator [141] can be optimized based 
on the outcome of simulations. Estimating temperature change based on the pattern of derived 
temperature profiles throughout the whole procedure may also be helpful for optimizing model 
predictive controller especially in the case of continuous thermal dose effects after turning of the 
thermal source [142].    
Magnetic Resonance Focused Ultrasound System (MRgFUS) is displayed in Fig. 2.18. In 
this system, a 16 element annular array is coupled to the animal resting position while performing 





Figure 2.18 An example of feedback controlled MFgFUS procedure (Image reproduced from Fite BZ et al., (2012) 
Magnetic resonance thermometry at 7T for real-time monitoring and correction of ultrasound induced mild 
hyperthermia. PLOS One 7(4): e35509. doi: 10.1371/journal.pone.0035509 [143]) 
MRI-HIFU is considered as a noninvasive and accurate image guided thermal therapy system 
because of its ability of real time temperature monitoring. Conjunction of MRI-HIFU with 
feedback control in hyperthermia experiment possesses a variety of advantages: 
- Providing anatomic information to manage the system settings 
- Real time temperature monitoring to limit damage to healthy tissue 
- Applying control feedback on the input power in correspondence to temperature change 
to keep the temperature in the mild hyperthermia range (39-42 °C) 
Figure below shows temporal evolution of temperature elevated and maintained constant inside 
the target utilizing a binary feedback control integrated with MRI-HIFU hyperthermia system. 




Figure 2.19 Temperature profile during MRI-HIFU hyperthermia experiment, (a) Temperature acquired by MR 
thermometry, (b) Time averaged temperature distribution inside and around the target (black dashed line) (Image 
reproduced with permission of Springer from Pharmaceutical Research, MRI-guided monitoring of thermal dose and 
targeted drug delivery for cancer therapy, vol. 30, 2013, 2709-17, R. Fernando et al. [105]) 
2.2.8. Post-treatment Verification  
Post processing has always been an important system in computer aided diagnosis (CAD) 
systems. Post processing techniques improve the quality of obtained image for a clearer 
visualization and higher analysis performance. Most common post processing methods includes 
contrast enhancement [144]–[149], image denoising [150]–[153] and filtering. Contrast increase 
can also occur during the experiment and, therefore, obtaining an enhanced image as the outcome 
of the scanning.  
Temperature sensitive contrast agents can be injected to the sample, ex vivo or in vivo, to 
enhance the thermal therapy image guidance. Gadolinium has gained interest among researchers 
as a MRI contrast agent [154], [154]. Gadolinium is a composition of paramagnetic 
thermosensitive liposomes which go through a phase transition based on a defined temperature. In 
vivo application of contrast agents are also investigated in which utilizing non-toxic agents holds 
a great significance [155], [156].   
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3. Simulation-based design and characterization of a microwave 
applicator for MR-guided hyperthermia experimental studies in 
small animals2 
3.1. Introduction 
Mild hyperthermia, moderate heating of tissue within the temperature range 40- 44 °C for 
30-60 minutes, has been clinically applied as an adjuvant therapy for sensitizing tumor cells to 
radiation and/or chemotherapy. The objective of clinical hyperthermia procedures is to maintain 
therapeutic temperatures within the targeted tissue for the duration of the procedure, while 
restricting temperature of non-targeted tissues below a specified threshold [158]. This is often 
challenging because tissue biophysical properties, especially blood perfusion, vary widely across 
patients and during the course of the hyperthermic exposure [38]. Treatment outcome following 
hyperthermia procedures is linked to the ability to deliver desired thermal dose profiles [159], 
[160]. Thus, practical systems for delivering hyperthermia should include methods for monitoring 
spatio-temporal temperature profiles so that energy delivery can be adjusted in real-time to achieve 
the desired thermal dose objectives. Hyperthermia delivery techniques and methods for 
temperature monitoring were recently reviewed by Faridi et al [45].  
                                                 
2 © IOP Publishing. Reproduced with permission. All rights reserved. This chapter was published as: P. Faridi, S. H. 
Bossmann, and P. Prakash, “Simulation-based design and characterization of a microwave applicator for MR-guided 
hyperthermia experimental studies in small animals,” Biomed. Phys. Eng. Express, vol. 6, no. 1, p. 015001, 27 




In addition to the therapeutic applications that are already in clinical use, the use of mild 
hyperthermia for modulating the anti-tumor immune response [161]–[163], targeted drug delivery 
[164]–[166], and other applications, is under investigation as the focus of ongoing research.  
Small animals have long been used for experimental tumor models as they can be 
genetically manipulated to host human disease, making them a powerful tool for researchers 
investigating the biological effects of anti-tumor therapies, including heating [24], [167], [168]. 
Similar to delivery of hyperthermia in humans, investigations in small animals require 
instrumentation suitable for delivering desired thermal dose profiles to targeted sites. Due to the 
considerably smaller size of small animals, investigations of therapeutic heating in small-animals 
often requires the development of instruments optimized for their size. An additional challenge 
during application of heat to small animals is maintaining core body temperature within 
normothermic limits.  
Hyperthermia may be administered with a variety of energy modalities, including high-
intensity focused ultrasound (HIFU) [143], [168]–[172] and electromagnetic energy, such as laser 
[106], [173], radiofrequency [174] and microwave [81], [83], [175] modalities. HIFU offers the 
advantage of non-invasive and precise energy delivery (~2 mm focal spot) due to the short 
wavelength and large penetration depth of acoustic energy at ultrasonic frequencies. However, the 
use of HIFU may not always be feasible because acoustic energy does not pass through bone and 
air in a controlled manner. Another commonly used technique for delivering hyperthermic 
exposures to small animals is the immersion of the tumor in a temperature-controlled water bath 
[166]. The water bath is easily administered, but since heating originates from thermal conduction, 
it can be difficult to achieve therapeutic temperatures within deep targets without overheating the 
skin and other organs that may be in thermal contact with the water bath. This places constraints 
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on the use of water-bath for applications where limiting heating to non-targeted tissues is essential 
e.g. survival studies.  
Microwave applicators operating at 2.45 GHz have been applied to mild heating of tumors 
in various small animal targets, including: bladder [83], lung [81], [176], and implanted tumors in 
the flank [177], [178] and hind limb [175]. A simulation-based approach was used to design and 
characterize a water loaded 2.45 GHz microwave applicator for delivering mild hyperthermia to 
the murine bladder [83]. In vivo studies showed that the applicator could be used to heat small 
tumors, at a depth of 2 - 3 mm beneath the skin, to the hyperthermic range, while maintaining core 
temperature below 40 °C.   
We have previously developed an experimental platform for delivering mild hyperthermia 
to experimental small animals integrated with ultra-high field 14.1 T MR thermometry [175]. The 
accuracy of MR thermometry at 14.1 T vs. fiber-optic thermometry was established (maximum 
discrepancy between MRI and fiber-optic thermometry ~ 0.4 °C) and an MR compatible 2.45 GHz 
directional water-cooled microwave applicator was employed to heat implanted 4T1 tumors 
(murine breast cancer) in the hind limbs of mice [175]. While this study demonstrated the 
feasibility of heating small-animal targets and simultaneously monitoring temperature profiles 
with 14.1 T MRI, the relatively broad heating profiles of the proof-of-concept applicators is not 
well suited for experimental studies where limiting heating in non-targeted tumors is essential. 
The objective of this study was to employ computational models to characterize the design 
of the proof-of-concept microwave applicator to focus heating (4 °C < ∆T < 5°C) within 2 – 4 mm 
targets located at 1 - 3 mm from the applicator surface, with minimal heating of adjacent regions 
(∆T < 4 °C). Such an applicator would be suitable for in vivo experimental studies in small-
animals, for delivering mild hyperthermia to 2 – 4 mm diameter tumors located at depths ranging 
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between 1 – 3 mm beneath the skin. As a first step, we employed MRI thermometry to characterize 
temperature profiles during heating with a prototype microwave hyperthermia applicator in order 
to assess the validity of computational models of microwave heating, and to identify antenna 
geometry and thermal cooling parameters that have the greatest impact on temperature profiles. 
Next, the experimentally validated computational models were employed to identify antenna 
geometry and circulating water flow parameters with the objective of maximizing therapeutic 
heating within simulated targets, while limiting heating in other regions. Finally, the most 
promising applicator design was fabricated and experimentally evaluated in tissue-mimicking 
phantoms during experiments performed under real-time MR thermometry. During these 
experiments, we evaluated the ability of the designed applicator to effectively heat targets at 
distances 1 – 3 mm from the applicator surface.   
3.2. Methods 
3.2.1. Computational model of the microwave hyperthermia applicator 
We employed multi-physics computational models to optimize 2.45 GHz water-cooled 
directional microwave applicators, similar to the design presented in [175], for non-invasive 
heating of targets in small-animals from a lateral position. As illustrated in figure 3.1, the applicator 
consists of a coaxial monopole antenna, with an eccentric monopole element displaced from the 
coaxial cable’s central axis, and a hemi-cylindrical metallic reflector to restrict energy deposition 
to approximately one half of the angular expanse. Water is circulated through the reflector tube to 
limit waste heating along the length of the applicator, and provide adequate impedance matching 
of the antenna to the feedline transmission line. Computational models were implemented to mimic 




 Figure 3.1 Geometry of the distal tip of the microwave hyperthermia applicator illustrating the monopole 
radiating element and metallic hemi-cylindrical reflector 
Here, we implemented 3D electromagnetic-bioheat transfer simulations with COMSOL 
Multiphysics, v 5.3. The model consists of the applicator positioned centrally within a 27 mm 
diameter cylindrical agar phantom, to mimic experimental procedures where the agar phantom is 
enclosed in a large Eppendorf tube (O.D. 30 mm; I.D. 27 mm) that fits snugly within the 30 mm 
imaging coil of a Bruker 14.1 T Advance III scanner. The model consists of two steps: computing 
the electric field radiated into the tissue and subsequently computing transient temperature profiles 
due to the absorbed electric field heat source. The model solves the time-harmonic Helmholtz 
equation to determine electric fields radiated to the tissue, subject to the following boundary 
conditions. The metallic parts of the applicator are defined as perfect electric conductors (PECs; 
i.e. conductivity, 𝜎 → ∞). Scattering boundaries were applied on all the outer surfaces of the 
model, and act to absorb electromagnetic energy at the model boundaries. A coaxial port boundary 
condition was applied at the proximal surface of the coaxial cable’s dielectric region to specify the 
excitation. 
Two types of heat transfer models were implemented; one model simulated heating in a 
homogenous agar phantom and was used for experimental validation of the computational model 
and design optimization of the applicator. A second model, in vivo model, included concentric 
layers of skin, fat and muscle, and used the Pennes’ bioheat transfer equation to account for the 
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effects of blood perfusion and metabolic heat generation [179]. Given the promising application 
of thermal models in previous studies [83], [179], [180], we employed a similar approach. 
Temperature dependant metabolic heat and perfusion rates after anesthesia were incorporated in 
the thermal models and was used to assess the impact of heterogeneity and physiological changes 
on the temperature profiles of the microwave applicator developed in this work. The 
electromagnetic power loss density, determined from the electromagnetic simulations, was used 
to specify the heat source. A convective heat transfer boundary condition at the outer wall of the 
catheter was used to approximate heat transfer due to circulating water within the applicator. For 
in vivo simualtions, we considered a multi-layer geometry incorporating multiple tissue types. The 
thickness of skin layer in mice ranges from 0.2 – 0.4 mm in males, and 0.13 – 0.2 mm in females, 
and the  thickness of sub-cutaneous adipose tissue ranges between 0.05 – 0.17 mm in males, and 
0.15 – 0.23 mm in females [181]. In our multi-layer model, we employed the largest thicknesses 
from these ranges for skin (0.4 mm) and sub-cutaneous fat (0.23 mm) layers. Table 3.1 lists 























(𝒌𝒈 𝒔−𝟏 𝒎−𝟑) 
Polyimide 3.4 [182] - - - - - - 









4182 [183] 0.6 [183] - - 
Muscle 52.7  1.74  1090 3421 0.49 1734[179] 2.161[179] 
Fat 10.8  0.268  911 2348 0.21 1734[179] 2.161[179] 
Skin 38 1.46  1109  3391  0.37 2002[179] 1.359[179] 
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Table 3.1 Material properties used in simulations 
a All material properties are from [184] except the indicated ones from [179], [182], [183] and measured properties in 
our laboratory.   
The applicator’s heating pattern, as assessed by specific absorption rate (SAR) profiles, 
can be controlled by modifying the reflector’s aperture and shape, as well as position of the 
monopole element, as shown in previous studies [185], [186]. The length of the monopole radiating 
element was restricted to 6 mm, for optimally matching the antenna at 2.45 GHz. Figure 3.2 depicts 
the antenna geometry parameters we investigated in this study: reflector angle (𝜃𝑟), monopole 
element shape (line or S-shape) and displacement from the center (m) to control the applicator’s 
SAR pattern.  
To assess the impact of microwave applicator geometry on the heating pattern, we modeled 
and implemented two applicators, one with ϴr1 = 150 °, m = 0.6 mm (applicator 1), and another 
with ϴr2 = 120 °, m = 1 mm (applicator 2). 
 
Figure 3.2. Schematic (left column) and photograph (right column) of fabricated microwave applicator 
geometry, (a) transverse view of reflector geometry, (b-c) longitudinal view of S (with 4mm monopole 
Blood  - - 1050  3617  - - - 
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element parallel to the outer catheter wall according to Sebek et al. [186]) and line-shape monopole 
radiation element with m displacement from the center of coaxial cable   
Besides the antenna geometry, the temperature (Tcool) and flow rate of water circulated 
within the applicator were expected to have an impact on temperature profiles, particularly, the 
extent of tissue adjacent to the applicator that could be thermally spared. To assess the effect of 
convective heat transfer on thermal profiles, we conducted microwave heating experiments in 
tissue mimicking phantom employing three flow rates, corresponding to different convective heat 
coefficient (h), and three cooling temperatures (Tcool). Temperature profiles during these 
experiments were measured using MRI thermometry. 
3.2.2. Experimental assessment of computational models 
Preliminary microwave heating experiments were conducted, with temperature profiles 
measured using 14.1 T MRI thermometry, with the objective of providing a dataset for  assessing 
the validity of computational models, and identifying the antenna geometry and circulating water 
flow parameters that have the greatest impact on thermal profiles. Specifically, we compared the 
measured and simulated  ∆T = 6 °C and 8 °C hyperthermic isotherms using the Dice Similarity 
Coefficient (DSC) defined using equation below, where X and Y are the measured and simulated 
isotherms. 





We conducted several microwave heating of tissue mimicking agar phantom integrated 
with real-time MR thermometry. During each of these experiments, one parameter of either 
geometry or convective heat transfer was considered as a variable while other parameters were 
kept constant. Table 3.2 summarizes the experimental settings of the described experiments. 
During these experiments, input power varied in the range of 4 – 11 W at the applicator.  
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Table 3.2 Experimental settings to assess the significance of the impact of each parameter 
Variable Geometry Tcool (°) Water flow rate (ml/min) 
Water flow rate applicator 1 Tphantom = 16.5  50   150 300 
Tcool applicator 1 13.5 16.5 29.5 150 
Geometry applicator 1   
applicator 2 
Tphantom = 16.5 150 
Geometry applicator 1   
applicator 2 
Tphantom = 16.5 150 
 
MR thermometry was implemented using a FLASH sequence with the following 
parameters: FOV = 30 mm, image size = 128 × 128, flip angle = 15°, TR/TE = 30.15/4.0 ms, slice 
thickness = 1 mm, scanning duration = 3.87 s. During the experiments, MR thermometry scans 
were acquired either three transaxial or sagittal slices, or one transaxial and sagittal slice 
simultaneously.  Models were implemented to mimic the experiments taking into account the two 
different applicator geometries and various heat transfer parameters.  
3.2.3. Parametric design of the microwave hyperthermia applicator 
The goal of the parametric design process is to adapt the microwave hyperthermia 
applicator design for treating targets of varying size located at varying depths within the small-
animal’s body. To evaluate the quality of a candidate applicator design, the following metrics were 
employed: (1) the fraction of the target volume covered within the desired hyperthermic range and 
(2) the fraction of surrounding non-target regions heated above a threshold.  
A two-stage design process was employed; 1) SAR-based geometry design; controlling 
electromagnetic power transfer to the tissue, 2) temperature profile-based selection of convective 
cooling parameters; assessing the impact of thermal parameters.  
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In the first stage, electromagnetic simulations were employed to identify the optimal S-
shaped monopole displacement, m, and reflector aperture angle, ϴr. The parameter m was varied 
in the range of 0 - 1 mm with the increment of 0.2 mm and ϴr was varied between 100 – 180° with 
increments of 10°. Candidate designs that delivered less than 30 % of applied power to the agar 
phantom (i.e. 70% of microwave power was absorbed within the applicator), were discarded from 
further consideration, as they would require excessively large applied input powers to heat tissue, 
which would compromise the efficacy of surface cooling due to microwave absorption within 
circulating water. Similarly, candidate designs that delivered more than 70% of power to the agar 
phantom were also discarded, as these designs yielded broad heating patterns.  
In the second stage, heat transfer simulations were employed to assess the most promising 
antenna designs, namely combinations of m, 0.4 and 0.6 mm, and ϴr, 160° to 100° with decrement 
of -10°, with convective heat transfer coefficient restricted to h =2000 [W m-2 K-1 ] (correspondence 
to flow rate of 150 ml/min). The combination of m and ϴr experiencing higher coverage and safety 
rates compared to the remaiming combinations, were saved as parametric design process applicator 
called applicator 3.  
To  determine the versatility of designs for delivering hyperthermia to a wide range of 
target sizes at varying distances from the applicator, input power and Tcool were introduced as 
control variables that could be selected by the user, and that are independent of the antenna 
geometry. The impact of varying these cooling parameters was assessed using transient heat 
transfer simulations over a period of 5 mins. 
Finally, the end result of this parametric design process, applicator 3, was incoporated in 
the in vivo model to assess the feasibility of delivering localized hyperthermia in the presence of 
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tissue heterogeneity taking into account the effect of anesthesia, blood perfusion and metabolic 
heat generation on the transient temperature profiles of applicator 3.  
Applicator 3 (with ϴr = 120 °, m= 0.6 mm) was fabricated, as illustrated in figure 3.3. We 
used a 3D template with an open angle of ϴr = 120° and an ID equal to the reflector OD (2.4 mm) 
to precisely machine the reflector dimensions. The monopole element was moved outward slightly 
greater than 0.5 mm relative to the ruler precision. The fabricated applicator has a resonance close 
to 2.45 GHz, and is well matched (i.e. s11 < -10 dB) over a 300 MHz bandwidth as shown in figure 
3.3 (d). The performance of this fabricated prototype was experimentally evaluated during 5 min 
and 30 min microwave heating experiments conducted under real-time MR thermometry. 
 
 
Figure 3.3 (a) Photograph of fabricated prototype of applicator 3 (outer catheter is not enclosed), (b) Cutting 
the reflector cylinder to the desired angle using a 3D printed template, (c) monopole element displacement 
from the center (m) measured with a 0.5 mm precision ruler, (d) applicator 3 reflection coefficient.  
During these experiments, a binary control scheme (i.e. bang-bang control) was employed, 
similar to Farr et al. 12.  The objective was to modulate the input power to keep the average 
temperature change of the pre-defined target ROI within the range 4 - 5 °C, while ensuring the 
maximum temperature change in the phantom did not exceed 8 °C (corresponding to 45 °C in- 
vivo presuming 37 °C as a normothermic temperature). We considered circular target ROIs with 
diameters of 2, 3 and 4 mm while specifying the distance between the applicator edge and ROI 
boundary as 1, 2, and 3 mm. Real-time temperature monitoring was performed using Thermoguide 
(IGT, Pessac, France), an MRI based temperature imaging software. To assess the performance of 
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the end result of parametric design process geometry and thermal design, we employed two cost 
functions to quantify the quality of the hyperthermic exposure: coverage and safety. The coverage 
metric defines the fraction of the target volume heated to the target temperature range (i.e. 4 °C < 
∆T < 8 °C). The safety metric is defined as the volume of the surrounding tissues (i.e. non-targeted 
regions) with temperature rise below 4 °C. Both the coverage and safety metrics are computed 
during the interval of time over which the binary controller was activated (See Fig. 3.10). Coverage 
and Safety were defined using the following functions:  
  Coverage = ∫








Since these metrics are competing, a desired applicator design and/or treatment delivery 
parameters has to be selected to balance the coverage and safety as prescribed by the constraints 
of the specific subject.  
3.3. Results 
3.3.1. Primary experimental characterization of microwave hypertehrmia 
applicators 
MRI thermometry maps and radial temperature profiles within agar phantoms after 5 min 
microwave heating are shown in figure 3.4. These data illustrate that the reflector aperture angle, 
ϴr, and the monopole shape and displacement, m, considerably affect the peak temperature and 
width and depth of the hyperthermic zone and provide degrees of freedom for modulating thermal 
profiles. Using the S-shaped monopole leads to more uniform heating along the applicator length, 
as demonstrated by the radial temperature profiles in different transaxial planes illustrated in figure 
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3.4 (d) and 3.4 (h). Further, the S-shape monopole affords thermal sparing of tissue immediately 
adjacent to the applicator, which is not feasible with the line-shaped monopole. 
 
Figure 3.4 MR thermometry temperature measurements after 3 and 5 minutes of heat exposure in a 
transaxial slice S2 with 10.6 W (b and f) and 7.2 W (c, d and g, h) input power, respectively using, (b - d) 
applicator 1, (f - h) applicator 2, (d) and (h) show the radial temperature profile in the direction of maximum 
heating labeled in (c) and (g), (three horizontal lines in sagittal views of the applicators inserted inside the 
phantom, (a) and (e), are showing three transaxial MR thermometry slices, S1, S2 and S3).   
Figure 3.5 shows the impact of varying the circulating water flow rate and temperature, 
Tcool, on radial temperature profiles when using applicator 1 in an agar phantom. Figure 3.5 (a) 
demonstrates that using a water flow rate of 150 ml/min enables sparing of regions adjacent to the 
applicator surface, while this region is heated to the hyperthermic range when using lower and 
higher flow rates. The effect of three different values of Tcool on radial temperature profiles is 
shown in figure 3.5 (b).  Increased Tcool leads to higher maximum temperatures, as well as 





Figure 3.5 Temperature profiles measured with MR thermometry while (a) water flow rate and (b) Tcool 
are adjusted.  
 
3.3.2. Experimental assessment of computational models  
Simulated and experimentally measured temperature maps are illustrated in figure 3.6. The 
DSC between the simulated and measured ∆T= 6 °C and 8 °C isotherms were 0.97 ± 0.02 and 0.98 
± 0.01, respectively, which suggests that computational model predicts temperatures that are in 
alignment with experimental measurements. We have previously comparatively assessed the 
validity of simulated transient temperature profiles in multiple ROIs with MR thermometry and 




Figure 3.6 Experimentally measured (first row) and simulated (second row) temperature profiles after (a-
b) 5 min of heat exposure with an input power of 7.2 W in transaxial view, (c-d) and (e-f) 3 min of heat 
exposure with an input power of 10 W in transaxial and sagittal view, respectively. Circulating water 
temperature (Tcool) is equal to phantom temperature (Tphantom) with flow rate of 150 ml/min. Full white 
circles and rectangles show the antenna position.   
3.3.3. Simulation-based parametric design and simulations under in vivo conditions  
Figure 3.7 displays normalized SAR profiles of a range of candidate applicator designs 
with varying ϴr and m . Based on these simulations, the number of candidate designs was narrowed 
down to 8 from an initial 30 combinations of ϴr and m, by considering only those applicators 




Figure 3.7 Normalized SAR profile of applicator designs employing varying combinations of ϴr and m 
(profiles are shown here for 12 out of a total 30 combinations that were investigated). 
At the end of thermal simulations, applicators with m = 0.4 mm and ϴr = 140° and m = 0.6 
mm and ϴr = 120° yielded higher Coverage and safety values compared to the rest of 
combinations. While both of these geometries could be employed for delivering hyperthermia to 
the target with similar coverage and safety values, the applicator with m = 0.6 mm and ϴr =120° 
was selected as the end result of the parametric design process, applicator 3, because of its 
adaptibility to larger number of target sizes and distances from the surface. Figure 3.8 depicts 
variations of temperature profiles in phantoms following heating with the optimal applicator 
design (ϴr = 120° and m = 0.6 mm), when using different combinations of applied power and 
Tcool. Figure 3.8 further illustrates that applicator 3 (ϴr = 120° and m = 0.6 mm), enables a range 
of temperature profiles that can be achieved with other applicator geometries, simply by adjusting 
the applied power level and Tcool. Importantly, adjusting applied power level and Tcool for other 




Figure 3.8 Simulated temperature profiles among the 8 remaining combinations of ϴr and m from SAR 
patterns that are well-suited for hyperthermia delivery to small tumors at t = 300 s with input powers of P= 
5, 6, 7, 8, 9 and 10 W, Tcool = 15°C or 20 °C while Tphantom is 20 °C. The red dashed border indicates the 
selected optimal design. Each column shows that temperature pattern achieved with the optimal desgin, by 
appropriately choosing applied power and Tcool, spans the range of temperature profile achieved by 
applicators with other ϴr and m combinaions; emphasizing that the optimal design embraces all the possible 
hyperthermic temperature profiles.   
Figure 3.9 depicts transient temperature profiles of in vivo model using applicator 3 which 




Figure 3.9 Transient temperature profiles of in vivo simulation using applicator 3 
3.3.4. Experimental evaluation of optimal applicator design 
Figure 3.10 illustrates MRI thermometry profiles following 7 W, 5 min heating of agar 
phantom using applicator 3 (ϴr = 120° and m = 0.6 mm). Temperature profiles are shown for 
exposures with and without feedback-control. Figure 3.10 (b) shows the average transient 
temperature during the application of binary temperature control (figure 3.10 (c)) which kept the 
average temperature of ROI (r = 1mm and D = 2 mm) in the target hyperthermic range.  
To evaluate the performance of applicator 3 for delivering hyperthermia to the target, 
control targets were defined, with r = 1, 1.5 and 2 mm, and D = 1 – 3 mm from the applicator 
surface (figure 3.11). Tables 3.3 and 3.4 include coverage and safety rates in transaxial and sagittal 
planes of each of the controlled hyperthermic experiments conducted with Tcool = Tphantom and Tcool 




Figure 3.10 (a) temperature profile measured by MR thermometry with P = 7 W at the applicator at t = 
300 s, (b) Average temperature profile during feedback-controlled heating, (c) Input power termination 
(21 W at power meter was equal to 7 W) and average temperature of the target ROI during feedback-
controlled heating. Tcool and Tphantom were both 18.5 °C with water flow rate of 150 ml/min. 
 
Figure 3.11 Temperature maps during 5 min heating (P=8 W) to maintain average temperature 
change of control ROIs with radius (a) 1 mm, (b) 1.5 mm and (c) 2 mm, in the range of 4 - 5 °C 
utilizing binary feedback control. D indicates the distance between the applicator edge and closest 
ROI boundary.  
Table 3.3 Coverage and safety of the controlled hyperthermia experiments in phantoms at a time 
following activation of the binary controller with Tcool = Tphantom 













Sagittal Axial Sagittal Axial t [s] 
Max Ave Max Ave 
1 1 6.8 4.2 7.7 4.3 100 86 99 88 89 80 43 
2 7.1 4.3 7.6 4.4 100 86 100 87 88 79 73 
3 6.9 4.1 7.5 4.2 99 84 99 84 87 78 112 
1.5 1 6.7 3.9 7.5 3.9 100 84 100 84 88 80 58 
2 7.4 4.2 8.1 4.3 98 75 98 77 87 79 104 




Table 3.4 Coverage and safety of the controlled hyperthermia experiments at a time following activation 
of the binary controller with Tcool = Tphantom – 5 °C 
 
Figure 3.12 illustrates the operation of the feedback-controlled power delivery approach 
and transient temperature profiles during 30 min of heat exposure. Figures 3.11, 3.12 and tables 
3.3 and 3.4, illustrate the capability of applicator 3 to deliver and maintain hyperthermic 
temperature to the targets of diameter 2 - 4 mm within 1 - 3 mm distance from the applicator 
surface. 
 
Figure 3.12 (a) Average temperature of target sized 3 mm in diameter located at 1 mm from the applicator 
boundary incorporating binary feedback control to trigger the input power (P= 7 W), (b) transient 
temperature profiles during 30 min heat exposure   
2 1 6.9 3.8 7.4 4 99 93 99 86 84 77 120 
2 7.2 4 8 4.2 93 81 95 83 80 76 190 
3 7.7 4.5 7.8 4 93 77 96 80 77 74 207 













Sagittal Axial Sagittal Axial t [s] 
Max Ave Max Ave 
1 1 6.6 4.2 7.4 4.2 100 77 99 73 89 80 104 
1.5 1 6.8 4.1 7 4.3 96 72 98 74 89 79 66 




Localized hyperthermia treatment requires (1) precise energy delivery to the targeted tissue 
and (2) maintaining the temperature in the hyperthermic range for 30- 60 minutes. In this work, 
we have optimized a previously presented non-invasive 2.45 GHz directional water-cooled 
microwave applicator to limit the extent of hyperthermic zone to 1 – 3 mm targets and preserve 
surrounding tissue. Real-time MR temperature monitoring and feedback control enabled 
maintaining temperature within the hyperthermic range. An advantage of the described system is 
it enables precise delivery of hyperthermia to small target sites with an easy to implement 
microwave applicator. Specifically, hyperthermic profiles to 1 – 3 mm targets could be controlled 
through selection of applied power level and Tcool. Compared to small-animal hyperthermia 
systems employing focused ultrasound, which may offer extended control of heating to deep seated 
targets, the presented system may afford simplified hyperthermia delivery, as it does not require 
careful selection of phased array excitation parameters [143], [169].  
We evaluated the impact of geometrical and thermal design of the microwave applicator 
on the temperature profiles. The evaluation of experimentally measured temperature profiles using 
the fabricated applicators with different geometrical design indicated that the reflector angle, ϴr, 
and monopole displacement from the center, m, modify the width and depth of the heating pattern 
and peak temperature. Specifically, increasing m moves the radiating monopole closer to the 
targeted tissue, which results in greater electromagnetic power absorbed within the tissue. 
Conversely, increasing ϴr results in more power remaining within the catheter. In addition to ϴr 
and m, the monopole antenna shape impacted the ability to shift the onset of the hyperthermic zone 
from immediately adjacent to the applicator surface, to deeper regions within tissue. This may be 
important because of the need to thermally spare the skin surface for several applications (figure 
59 
 
3.4). During experimental evaluation of thermal parameters, using a convective heat transfer rate 
of 150 ml/min increased radial penetration of the peak temperature from the surface of the 
applicator compared to flow rates of 50 ml/min and 300 ml/min (figure 3.5). This enables increased 
skin cooling and treatment of tumors up to 4 mm from the skin surface. The choice of Tcool relative 
to Tphantom has a considerable impact on the temperature profile. High values of Tcool leads to 
convective heating, in addition to direct microwave heating, which increases the tissue 
temperature, particularly at the applicator boundary, and broadens the extent of the hyperthermic 
zone (figure 3.5). Temperature rise also appears along the applicator length due to convective 
heating which heats up the whole tissue sample. Therefore, circulating water with higher 
temperature relative to tissue sample is not suitable for localized hyperthermia delivery to small 
animal targets. Using lower Tcool reduces the peak temperature, as well as the width of the 
hyperthermic zone. 
Temperature profiles predicted by the 3D computational model were comparatively 
assessed with MRI thermometry data from experiments in tissue-mimicking phantoms. The 
hyperthermic isotherms of measured and simulated temperature profiles were highly correlated 
(DSC = 0.95 – 0.99) for multiple input powers (figure 3.6). The validated computational models 
were then utilized for design and characterization of the applicator based on the normalized SAR 
and temperature profile. For the SAR-based parametric design (figure 3.7), monopole shape was 
restricted to S-shape because of the ability to thermally spare regions between the applicator edge 
and the hyperthermic zone. This gap lowers the risk of skin burn during in vivo hyperthermia 
treatments. From thermal simulations, using a convective heat transfer coefficient of h=2000 
[W/m2 K] (corresponding to a flow rate = 150 ml/min), ϴr = 120 °C and m = 0.6 mm was selected 
(applicator 3), because compared to other ϴr and m combinations, this selection enabled heating 
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of a wider range of target sizes at greater distances from the skin, while maintaining a similar 
safety rate. It is worth noting that the range of thermal profiles that can be achieved by applicator 
3, by appropriate selection of Tcool and applied power, spans the range of temperature profiles 
achieved by the majority of the eliminated designs, which have distinct antenna geometries (figure 
3.8).  
The ultimate goal of the parametric design process was to identify an applicator design 
suitable for delivering localized hyperthermia to small animal targets in vivo. The temperature 
profiles predicted by computational models using applicator 3 when considering a multi-layer 
perfused skin, fat and muscle layer and metabolic rate after anesthesia (mimicking in vivo 
treatments) demonstrate the suitability of using the design presented in this work for localized 
heating of small-animal targets. Comparing the temperature profiles simulated under in vivo 
conditions (figure 3.9) in a multi-layer medium, including blood perfusion and metabolic heat 
generation, with temperature profiles in the homogeneous phantom (figures 3.6 and 3.8), it is 
apparent that, for the same applied power level, the shape of the hyperthermic zones remain 
similar, suggesting that the shape of the hyperthermic profiles are not substantially impacted by 
dielectric heterogeneity. However, for the same applied power level, the peak temperature and the 
volume raised to the hyperthermic temperature in in vivo simulations compared to homogeneous 
phantoms is decreased, which may be attributed to the additional heat sink terms. We anticipate 
that applying power using the binary feedback control algorithm would facilitiate increased peak 
temperatures and hyperthermic treatment zones, although these may still remain below the size of 
hyperthermic zones that could be achieved in homogenous phantoms. It is noted that we employed 
a simplified model where the skin, fat, and muscle layers were geometrically modeled as 
concentric cylinders. While these simulations illustrate the impact of heterogeneity and blood 
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perfusion and metabolic heat generation on thermal profiles compared to those simulated in 
homogeneous agar phantoms, models incorporating the anatomy of the animal [80], [83] may 
provide a more comprehensive prediction of temperature profiles for a particular administration of 
heating.  
Integrating applicator 3 with binary temperature-based feedback control of applied power, 
localized the heating to the targeted region of interest (figure 3.10). Real-time MR temperature 
monitoring using applicator 3 with the application of temperature feedback control enabled precise 
delivery of hyperthermia to target ROIs over a narrow temperature range (4 - 5 °C) (figure 3.11). 
The average temperature within the targeted ROI reached the hyperthermic range within a few 
minutes; for example, hyperthermic temperatures for target ROIs with r = 1 mm and D = 1 mm 
were obtained after 43 s, and for target ROIs with r = 2 mm and D = 3 mm, after 207 s. In this 
study, binary feedback control was employed to terminate the input power when average 
temperature change of the pre-defined target ROI reached 5 °C. The uniform distribution of 
hyperthermic temperatures in the selected ROIs, compared to non-uniform distribution previously 
reported for MR-guided pancreatic hyperthermia in mice [168], may facilitate in vivo hyperthermia 
treatment for target sizes of 2 - 4 mm in diameter in 1 - 3 mm distance from the applicator yielding 
high target coverage (tables 3.3 and 3.4). The placement of the monopole antenna could change 
the maximum temperature of the target by 1 - 2 °C. However, average temperature of the target 
ROI remains in the hyperthermic zone with relatively high coverage and safety rates (safety = 74 
- 77 %; coverage = 80 - 94 %).  
Figure 3.12 illustrates the feasibility of using applicator 3 integrated with feedback control 
for delivering hyperthermia over a 30 min period. During 30 min of heating, hyperthermic zones 
remained confined to the target while maintaining the safety rate of non-targeted surroundings. 
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We calculated the safety and coverage metrics over an average of 60 s prior to the timepoints 
shown in figure 3.12. The safety metric ranged between 77 – 79 %, and the coverage metric ranged 
between 70 – 90 %. These data illustrate the ability of the proposed system to maintain localized 
heating to targeted regions over an extended duration of time. While baseline drift is known to be 
a potential source of error during MRI thermometry for long durations [169], we observed the 
maximum drift over 60 min to be 0.4 °C; further, this level of drift could be corrected with 
established drift compensation techniques [188]–[190]. 
A limitation of this work is the absence of in vivo experiments. The dissimilarity between 
in vivo and phantom studies are tissue heterogeneity, blood perfusion, metabolic heat generation 
and small animal movement inside the MR scanner. Although the optimal system described here 
was not employed to deliver hyperthermia to small animals, we expect accurate energy in vivo 
delivery according to the temperature profiles of validated 3D in vivo computational models. In 
this study, we applied feedback control relevant to temperatures measured in one transaxial plane, 
however, temperature was monitored in sagittal plane simultaneously to avoid temperature rise 
above 8 °C. Coverage and safety rates in sagittal plane were similar to those measured in the 
transaxial control plane.    
3.5. Conclusion 
We employed a model-based approach for the design and characterization of 2.45 GHz water-
cooled microwave applicators for delivering hyperthermia to small-animal targets under 14.1 T 
MRI guidance. Computational models of microwave heating were experimentally validated and 
used to comparatively assess the range of applicator parameters that affect thermal profiles, 
namely: monopole antenna shape and displacement, reflector aperture angle, circulating water 
temperature, and flow rate. The result of the parametric design process, applicator 3, employed a 
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reflector with aperture angle ϴr = 120 °C and an S-shaped monopole displaced 0.6 mm from the 
antenna’s central axis. Adjusting the applied microwave power and circulating water temperature 
enabled using the selected applicator design to deliver hyperthermic profiles to a range of target 
ROIs. In experiments using applicator 3, a binary feedback control scheme was employed to 
deliver heating to target ROIs targets 2 - 4 mm in diameter positioned 1 - 3 mm from the applicator 
surface. In these experiments, 76 - 93 % of the target ROI was heated to the target temperature 
while 74 - 89 % of non-targeted regions were maintained below the hyperthermic threshold.   
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4. Evaluation of the effect of uterine fibroids on microwave 
endometrial ablation profiles3 
4.1. Introduction 
Thermal ablation is a minimally invasive technique employed for treatment of menorrhagia 
(i.e. excessive menstrual bleeding) [191]. The objective of the procedure is to thermally coagulate 
vessels in the endometrial lining of the uterus, while precluding thermal damage to the 
myometrium and other tissues. Systems employing a variety of energy modalities including 
radiofrequency [192], laser [193], hot water/steam [194] and cryotherapy [195] are in clinical use 
for endometrial ablation. Thermal ablation may be delivered to the endometrium in a global or 
local manner. Local ablation refers to delivering energy to a small localized region, requiring the 
physician to translate the instrument within the cavity in order to achieve adequate ablation of the 
entire target  [196]. Global endometrial ablation procedures deliver therapeutic energy to the entire 
endometrium in a single application of energy, without requiring repositioning of the applicator.  
Microwave ablation systems have been developed for treatment of tumors in  the liver and 
other organs [197], and are under consideration for treatment of other indications. We have 
recently presented a system and applicator for global microwave endometrial ablation. The 
applicator includes a triangular loop antenna that is deployed within the uterine cavity, and delivers 
microwave energy at 915 MHz. 
                                                 
3 © 2018 IEEE. Reprinted, with permission, from P. Faridi, H. Fallahi, and P. Prakash, “Evaluation of the Effect of 
Uterine Fibroids on Microwave Endometrial Ablation Profiles,” in 2018 40th Annual International Conference of the 




The ablation profile of the fabricated applicator was experimentally assessed in ex vivo 
tissues and was found to yield ablation depths within the standard range of 4 -10 mm required for 
endometrial ablation [198]. While our previous work has established the technical feasibility of 
delivering microwave energy to the uterine cavity for endometrial ablation, the sensitivity of the 
treatment outcome to heterogeneity in 
 
Figure 4.1 Uterus geometry with single loop applicator in the uterine cavity on the left and 3 
different fibroid types on the right 
 
tissue dielectric properties, and non-ideal deployment of the antenna requires further investigation. 
Computational models of microwave ablation are an established method for assessing the 
sensitivity of ablation outcome to tissue biophysical properties [199].  
Uterine fibroids, abnormal uterine muscle growth, are the most common pelvic tumor in 
women [200]. Fibroids grow either entirely or partially within the uterine cavity, and may alter the 
cavity shape. Fibroids are classified relative to their location within the uterus, as follows [201]: 
• Submucosal fibroid: drives the endometrium toward the uterine cavity  
• Intramural fibroid: grows within the uterine wall 
• Subserosal fibroid: moves outward from uterine cavity 
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Fig. 4.1 illustrates the microwave ablation antenna deployed within a uterine cavity without 
fibroids, as well as example locations of submucosal, intramural, and subserosal fibroids. Fibroids 
are further categorized based on their pattern in the uterine wall and cavity. A solitary fibroid is a 
single fibroid of diameter 1-9 cm, while multiple small fibroids (number ranging from 4 to 20) 
may exist in proximity to each other, with fibroid being less that 12 cm [202]. 
As shown in Fig. 4.1, submucosal fibroids may push the endometrium towards the interior 
of the cavity and have potential to deform the shape of the deployed applicator. The objective of 
this work is to assess the sensitivity of microwave ablation in the presence of solitary uterine 
fibroids of diameter in the range of 1 – 3 cm. Since fibroids may have considerably different 
dielectric properties relative to uterus tissue due to variations in water content and also, as 
mentioned above, alter the applicator shape, we have assessed the effect of these two parameters, 
fibroid dielectric properties and applicator geometry change, using an experimentally validated 
computational  model.  
4.2. Method 
We employed computational models of microwave tissue heating to numerically assess the 
effect of fibroids on the endometrial ablation profile. First, we  assessed the validity of the model, 
by comparing simulated and experimentally measured ablation profiles. Next, we implemented 
simulations incorporating 1 – 3 cm fibroids in varying simulations, to assess their impact on 
ablation profiles, compared to those predicted by simulations in the absence of fibroids. 
4.2.1. Experimental validation of GEA computational models 
 A 3D numerical model to simulate electromagnetic wave propagation, power deposition, 
and heat transfer, implemented with COMSOL Multiphysics, was employed for evaluating thermal 
ablation profiles generated by a 915 MHz loop antenna, previously reported in [198] The  antenna 
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is built from UT-47 coaxial cable, with the outer conductor stripped over a 125 mm length, 
exposing the insulated inner conductor. The insulated inner conductor is shaped in a triangular 
loop and is electrically connected to the outer conductor, as illustrated in Fig. 4.2. Details of the 
computational model are presented in [198]. Briefly, the model solves the Helmholtz 
electromagnetic wave equation to determine the electric fields radiated into tissue. The model then 
determines transient temperature profiles using the absorbed electromagnetic power as the heat 
source. For these 60 W, 150 s ablations, the 60 C isotherm was used as an estimate of the ablation 
zone extent.   
 The computational models were implemented to mimic the configurations employed for 
experimental evaluation of fabricated prototypes. Since ablation profiles created by the prototypes 
were assessed in ex vivo liver tissue, a widely used tissue model for evaluating thermal therapy 
devices [203], models used for comparison to experiment simulated ablations in liver tissue. One 
vertical and three horizontal cut-planes, equivalent to cuts applied to the liver tissue to evaluate 
the ablation profile in the experiment are considered for comparison to simulated ablation profiles, 
as illustrated in Fig. 4.2. The maximum difference in the ablation depth of all four cut planes are 
determined to compare the computational and experimental outcomes. 
4.2.2. Modeling of uterine fibroids 
After comparing experimentally measured and simulated ablation profiles, we adapted the 
model to include dielectric and thermal properties of uterine tissue. An important step for 
simulating microwave ablation in the presence of uterine fibroids is to develop suitable dielectric 
property models. To our knowledge, only a single measurement of fibroid dielectric properties at 
100 MHz has been reported in the literature [204]. Since fibroids are an overgrowth of uterine 




Figure 4.2 Computational model geometry with 4 cutplanes correspondance to experimental 
tissue pieces 
properties by scaling the dielectric properties with scaling factor M, in the range of 0.5 – 1.5  that 
of uterine tissue, as illustrated in Table 4.1, to represent increased or decreased water content, as 
compared to normal uterine tissue [205]. 






Next, we added solitary fibroids of diameter 1 – 3 cm to the left and right side of the uterine 
wall (myometrium) and the fundal region of uterus. In our models, we incorporated both fibroids 
that did and did not modify the shape of the deployed applicator.  Fig. 4.3 shows four examples of 
the model geometry with fibroids of different sizes located at various sites. We compared changes 
Multiplication 
factor (M) 
Tissue dielectric properties 
Permittivity, ε   Conductivity, σ (S/m) 
0.5 30.55 0.64 
0.8 48.88 1.02 
1.2 73.32 1.54 
1.5 91.65 1.92 
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in the antenna’s specific absorption rate (SAR) and temperature profiles in the presence of fibroids, 
to the SAR and temperature profiles, in the absence of fibroids. 
 
Figure 4.3 Computational model geometry for (A) and (B) 1 and 3 cm fibroid squeezing the 
endometrium, (C) and (D) 2 and 3 cm fibroid touching the endometrium, * indicates the 8 mm 
endometrium gap between the fibroid and applicator 
 
4.3. Results and discussions  
Fig. 4.4 illustrates simulated and experimentally assessed temperature profiles in ex vivo 
liver tissue. Table 4.2 compares the simulated and measured ablation depth of the four 
measurement cut planes, as described in [198]. The average and standard deviation of the 
maximum discrepancy between simulated and experimentally measured ablation depths across the 
four cut planes was 1 ± 0.8 mm. These data illustrate the suitability of using computational models 
for estimating extents of ablation zone created by the 915 MHz microwave loop antenna. 
Fig. 4.5 shows SAR patterns of the applicator with 60 W input power in the presence of 
fibroids of varying size and dielectric properties. As seen in Fig 4.5, both variations in dielectric 




Figure 4.4 Ablation profiles at time 150 s for ex-vivo liver tissue bench-top experiment and 
compuational modeling with an input power of 60 W on 4 different cut planes, black and blue 
dashed line on each simulation cut plane indicate a 60 °C contour for experimental and simulated 
liver tissue, repectively. Red dashed line segments the ablation depth for each cut plane of ex-vivo 
experiment. 
Compared to the SAR pattern in a uterus without fibroids, changes in the SAR pattern were more 
significant for large fibroids that modified the shape of the deployed antenna, than changes due to 
dielectric heterogeneity between fibroids and background uterine tissue.    
Fig. 4.6 illustrates simulated temperature profiles in four cut planes for a 3 cm fibroid in 
the fundal region, with four different dielectric property. The maximum distance between 
simulated extents of the ablation zone with and without fibroids, are noted on the illustration in 
Fig.4.6. Despite the SAR pattern change in Fig. 4.5, ablation depths in the four cut planes remain 
within the desired range defined for endometrial ablation, and are similar to simulated ablation 
depths for the case without uterine fibroids. There was little change in ablation depth across the 
range of dielectric properties of fibroids. Table 4.2 lists the maximum discrepancy in the ablation 
zone depth for fibroids located on the right or left walls of the uterine cavity.  In this table, we have 




Figure 4.5 Electromagnetic power depostion through uterine tissue without (A) or with (B-E) 
fibroid, (B) 1 cm fibroid touching the endometrium in the fundus, (C) 1 cm fibroid squeezing the 
endometrium on the left uterine wall, (D) 2 cm fibroid in the fundal region pushing the 
endometrium toward cavity, (E) 3 cm fibroid squeezing the endometrium on the right 
myometrium, dielectric properties for B-E are determined in Table 4.1 , rows 1-4, respectively. 
 
 
Figure 4.6 Temperature profiles of 3 horizontal and one vertical cut planes for a SAR pattern 
generated by fibroid squeezing the endometrium on the fundal region, solid black line and 4 
colored dashed lines indicate the 60 °C for plain uterus tissue and uterus with fibroid of 4 distinct 
dielectric properties. Values indicate the maximum difference (in mm) between uterus without and 
with fibroids with dielectric properties of Table 4.1. 
changes in the applicator geometry. 3 cm diameter fibroids with dielectric properties that are 0.5 
and 1.5  uterus properties yield the greatest discrepancy among all the selection choices of fibroid 
dielectric properties, sizes and applicator modifications. Table 4.3 indicates that the differences 
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are in the range of 0.36 ± 0.33 mm. 
 
























A limitation of this study is that we did not include the effects of blood perfusion in our 
models. While we employed a wide range of dielectric properties for fibroids compared to normal 
uterus, our models did not include any heterogeneity in tissue thermal properties. Although we 
Absolute discrepancy  between experimental [198] and simulated ablation depth 
[mm]  following 150 s heating experiments 
 Experiment [198]  Simulation 
Horizontal cut 
Top 
Left 5.5 7 
Mid 6.5 6.5 
Right 5.5 5.3 
Mid 
Left 6.9 8.5 
Mid 9.5 10.3 








Top 6.3 7.1 
Mid 8.6 9.9 
Bottom 5.3 6.7 
Maximum ablation depth [mm] discrepancy for 3 cm fibroid 





Left myometrium Right myometrium 
Top Mid Bot Ver Top Mid Bot Ver 
0.5 0.6 1.0 0.1 1.1 0.0 0.1 0.0 0.3 
1.5 0.6 0.4 0.3 0.7 0.0 0.1 0.0 0.0 
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have employed uterus tissue properties in the ex vivo liver tissue experimentally validated models, 
uterine tissue was not employed in any of bench top ablation experiments Future studies 
characterizing the biophysical properties of normal uterine tissue and fibroids are warranted. 
4.4. Conclusion 
We employed computational models to assess the impact of 1 – 3 cm diameter uterine 
fibroids with dielectric properties in the range of 0.5 – 1.5  that of uterine tissue on microwave 
endometrial ablation profiles. Models predicted that the depth of ablation zones in the presence 
of fibroids were within 0.36 ± 0.33 mm of simulated ablation zones in the absence of fibroids. 
These findings suggest that 915 MHz loop antennas designed for endometrial ablation may yield 




5. Experimental assessment of microwave ablation computational 
modeling with MR thermometry4 
5.1. Introduction 
Computational models of thermal ablation procedures aim to predict the extent of the thermal 
ablation zone, which is a function of the transient temperature profile within the heated tissue, for 
a candidate set of treatment delivery parameters. Models of microwave ablation (MWA) are 
widely used during the design and optimization of ablation applicators, and are also frequently 
used to characterize applicator performance as part of regulatory submissions [157], [206]–[208]. 
Models are also used for comparative assessment of energy-delivery strategies [209] and for 
assessing the impact of various sources of uncertainty on ablation outcome [199], [210]–[213]. 
Recently, there has been growing interest in the development of computational models for guiding 
planning of clinical ablation procedures, and for assessing treatment outcome [214]. Experimental 
validation of MWA computational models is important to provide confidence in model predictions 
[30], [215]–[218] and may contribute to increased use of modeling tools in the clinical setting. 
Although the ultimate application of MWA technology is in pathologic tissue in the in vivo setting, 
extensive validation in the controlled ex vivo tissue environment represents an important first step 
for establishing model credibility. 
MWA computational modeling consists of 1) defining the geometry of the ablation applicator 
and the medium (or media) within which the applicator is inserted; 2) assigning biophysical 
properties to each domain of the simulation geometry; 3) discretizing the computational domain, 
                                                 
4 © 2020 American Association of Physicists in Medicine, Reprinted with permission, from P. Faridi, P. Keselman, 
H. Fallahi, and P. Prakash, “Experimental assessment of microwave ablation computational modeling with MR 
thermometry,” Med. Phys., 2020. http://dx.doi.org/10.1002/mp.14318 [44] 
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and solving the electromagnetic, bioheat transfer, and other equations, subject to the specified 
initial and boundary conditions. The electromagnetic power density profile serves as the heat 
source for the bioheat transfer equation [5] . The output of the MWA computational model is 
transient temperature profile from which thermal damage can be estimated [219]. The model 
outputs may be affected by several sources of uncertainty and variations (e.g. substantial changes 
in thermal and biophysical properties due to temperature change [220]).  
Validation of a computational model is defined as determining the degree to which the model 
accurately represents of the physical world given the intended use of the model [221].   Validation 
of MWA computational models may be performed by comparing model outputs, such as transient 
temperature profiles and extents of the thermal damage/ ablation zone, with experimental 
measurements.  A widely used approach to assess the validity of MWA models is to place point-
based temperature sensors at a few discrete points during experimental ablations, and to compare 
the measured temperatures with simulated temperature profiles at the same location [5]–[7]. To 
compare the extent of the ablation zone, simulated thermal damage maps, derived from transient 
temperature profiles, may be compared with the extent of visibly discolored tissue. This 
comparison provides an additional level of validation as it accounts for the ablation zone size and 
shape, in addition to the transient temperature profiles at a few discrete points. However, 
determining the boundary of the experimental ablation zone (i.e. segmentation) may be subjective 
prone to inter- and intra-observer bias [222], and challenging with some tissue types, e.g. lung 
tissue in which ablation zone boundary may be diffuse and not visibly separated from the healthy 
tissue background [223]. In addition to providing temperature measurements at a large number of 
points, methods for measuring the transient evolution of spatial temperature profiles during 
ablation would enable calculation of the extent of the ablation boundary, for example, using the 
76 
 
Arrhenius thermal damage model [219]. In order to provide transient temperature profiles at more 
than just a few discrete points, infrared cameras have been used to measure spatial temperature 
profiles during MWA experiments [29]. However, this technique only provides surface 
temperature measurements and requires experimental apparatus that provides an optical window 
in the heated tissue, thus making it unsuitable for volumetric temperature measurements during 
ablation.  
Magnetic resonance imaging (MRI) provides a means for spatial measurement of transient 
temperature profiles in multiple planes. A number of temperature-sensitive MR parameters have 
been investigated for monitoring of thermal therapy procedures, with the most widely used 
approach being the proton resonance frequency shift (PRFS) technique [39], [120]. Although 
tissue dielectric changes may lead to PRFS-measured temperature errors due to phase retardation, 
it should not significantly affect the temperature measurements when the heated volume is 
restricted to a small fraction of the imaged sample [224]. While MR thermometry has been widely 
applied for monitoring and guiding delivery of ultrasound and laser ablation [106], [143], [170], 
[225], [226], it has not been widely used with microwave ablation systems. Integrating microwave 
ablation systems with MRI may be challenging due to the need to design the ablation applicators 
and feeding cables from MRI-conditional materials, as well as considerable attenuation in long 
feeding cables due to the requirement that the microwave power source is placed outside the 
scanner room [227]. Some prior studies have investigated the use of 1.5 T MRI thermometry for 
monitoring microwave heating of ex vivo tissues such as brain, muscle, liver, kidney, in vivo rabbit 
brain, as well as ablation of prostate cancer in humans [228]–[230]. In these studies, MR 
thermometry images were acquired with different imaging sequences such as spoiled gradient-
recalled echo (SPGR) and fast-SPGR in a single plane with an update time of ~13 – 26 s. Prior 
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studies have also employed gradient eco sequences (GRE) with Z-shimming for minimizing 
artifacts in the proximity of metallic microwave ablation applicator [231]. With advances in MR 
thermometry sequence development, multi-slice thermometry with update times of under 10 s are 
now available, offering a potential avenue for 3D measurement of transient temperature profiles 
during ablation procedures [120].  
In our earlier study [187], we presented a preliminary assessment of 3D computational 
models of microwave thermal therapy (over the temperature range 20 °C – 45 °C) in an agar 
phantom using a 14.1 T ultra-high field small-animal MR scanner. Due to the limited size of the 
high-field small-animal scanner, the phantom diameter was restricted to 27 mm, and the use of 
power levels typically used during ablative exposures was precluded. The objective of current 
study was to develop an experimental MWA platform integrated with 3T MRI and to apply this 
platform for assessing the thermal profiles predicted by computational thermal models in 
comparison to thermal profiles measured with Magnetic Resonance Thermometry (MRT). We 
used a custom 2.45 GHz, water-cooled, microwave applicator for MWA experiments in ex vivo 
tissue performed inside the 3T MRI scanner. A 3D MWA computational model was implemented 
to predict transient temperature profiles during 30 – 50 W microwave exposure. Volumetric 
temperature maps and thermal damage profiles measured using MRT were compared to profiles 
predicted by MWA computational models. To further analyze the sources of uncertainty in 
measured temperature profiles, we studied the sensitivity of parameters affecting the model output 
and compared to experimentally measured thermal damage using our developed MWA platform. 
5.2. Materials and methods 
The overall goal of this study was to assess 3D transient temperature and ablation profiles 
predicted by MWA computational models with temperature profiles measured experimentally 
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using MRT. Measured transient temperature and ablation zone profiles were compared directly 
against model predictions. A sensitivity study was conducted to assess the impact of various 
sources of uncertainty on model outputs, for comparison against variability in experimental 
measurements. 
5.2.1. Ex vivo tissue MR-guided microwave ablation experimental setup  
We developed a custom apparatus for conducting MWA experiments in ex vivo tissue within 
the 3T MRI environment (Fig. 5.1). The MWA system consists of a 200 W, 2.45 GHz solid state 
generator (SAIREM, GMS 200 W, Neyron, France), peristaltic pump (Masterflex, 07554-90, 
Vernon Hills, IL), and a custom, water-cooled, microwave applicator fabricated from MR-
conditional materials. The microwave generator was connected to power monitoring 
instrumentation (BirdRF 7022 statistical wideband power sensor, Bird Technologies, Solon, OH) 
to keep track of power delivered to the applicator. The generator, power monitoring 
instrumentation, and peristaltic pump were placed outside the MRI room in the controller room. 
The water-cooling lines and the fiber-optic temperature probe extensions were introduced into the 
scanner room via a waveguide. The microwave signal was coupled to the MWA applicator inside 
the MRI room via a penetration panel. The coaxial cable and water line tubing between the 
generator, pump and the applicator were 6 m long (5 m from microwave applicator to waveguide 
and 1 m from waveguide to the generator). This length of cables in between the microwave 
generator and the MWA applicator placed limits on maximum power applied at the MWA 
applicator connector. Considering the attenuation level of cables, with a generator of maximum 




Figure 5.1 Block diagram of the microwave ablation system integrated with 3T MRI 
We performed MWA in ex vivo tissue (bovine liver) under 3T MRT guidance using a custom, 
2.45 GHz cylindrically-symmetric water-cooled applicator. As illustrated in Fig. 5.2, the ablation 
applicator consists of a monopole antenna created by modifying the distal tip of a low-loss, coaxial 
cable with a non-magnetic copper jacket (UT-047C-LL; Microstock, Inc, PA, USA) to expose the 
center conductor. The antenna is concentrically positioned within a water in-flow tube (FEP, O.D. 
= 2 mm; I.D. = 1.4 mm) and an outer tube (PEEK, O.D. = 2.54 mm, I.D. = 2.4 mm) that provides 
a return flow path. Water flow around the distal tip of the radiating antenna, was employed to 
remove waste heating along the applicator’s shaft due to attenuation within the coaxial cable, as 





 Figure. 5.2 Geometry of the distal tip of the microwave ablation applicator 
MR thermometry data were acquired on a 3T Siemens Skyra scanner using a vendor provided 
15-channel Tx/Rx knee coil in one coronal (parallel to microwave ablation applicator) and two 
axial planes (perpendicular to coronal view). One axial plane was aligned with the distal point of 
fiber-optic temperature probes while the second one was placed 13 mm apart distally, to capture 
thermometry data in a plane near the tip of the radiating antenna element as illustrated in Fig. 5.1. 
Phase and magnitude maps were reconstructed from a series of fast low-angle shot (FLASH) 
images (TR/TE = 50/12.3 ms, FOV = 128 x 128 mm2, matrix = 128 x 128, flip angle = 15°, slice 
thickness = 1.5 mm and acquisition time = 6.4 s per image) to measure changes in tissue 
temperature. The PRFS method, a widely used MR temperature monitoring technique, was utilized 
in this work to measure temperature changes during microwave heating [39], [120]. In this work, 
a fast spoiled GRE sequence (FLASH) was used due to its relatively short TE/TR, which decreases 
the scanning time that is appropriate for temperature monitoring and high accuracy in temperature 
monitoring spatially and temporally while maintaining a relatively high SNR [143]. 
To compensate for the magnetic field drift of MRT at 3T, we applied the phase drift correction 






Δ𝜙(𝑡) = 𝜙(𝑡) − 𝜙(0)






where 𝛼, 𝛾, 𝐵0 and 𝑇𝐸 are the PRF temperature coefficient, gyromagnetic ratio, the magnetic field 
and echo time defined in the MR scanning sequence, respectively. In the above equation, Δ𝜙(𝑡) is 
the phase change due to both temperature and other changes and 𝜙𝑑𝑟𝑖𝑓𝑡(𝑡) is a 3×3 region of interest 
(ROI) selected far away from the applicator where no temperature change was expected. The first 
phase image during course of experiment was considered as the reference image, 𝜙𝑑𝑟𝑖𝑓𝑡(0), which 
was subtracted from the all other images to capture the non-temperature phase changes.   
A total of 13 ablation experiments were conducted using 30 – 50 W applied power at the 
applicator input (corresponding to 100 – 180 W power level at the generator). MRT data were 
acquired for 2 min prior to heating, during 5-10 min microwave exposures, and for 3 min following 
heating. The MWA applicator was inserted 5 cm deep inside the tissue. Two fiber-optic 
temperature probes were introduced during ablation experiments to compare the monitored 
temperatures to MRT measurements (FO1 at 5 mm and FO2 at 35 mm radially from the applicator). 
The fiber-optic temperature probes were placed at pre-defined depths in regions where peak (FO1) 
and moderate (FO2) temperatures were anticipated. FO1 was axially aligned to be in proximity to 
the junction of the coaxial outer and inner conductors. Initial tissue temperature was also monitored 
by FO1 and FO2, which later was used as a baseline temperature for MRT measurements to 
determine absolute temperature of tissue during ablation experiments. We used a 8×8×8 cm3, 1 cm 
thick custom-made 3D printed container (polylatic acid, PLA, filament) to hold the same volume 
of ex vivo tissue for each experiment. The container’s lid (1.5 cm thickness) had 3 holes to align 
the fiber-optic temperature probes with the microwave applicator at 5 mm and 35 mm radial 




5.2.2. Microwave ablation computational modeling 
We implemented MWA computational models using the finite element method with COMSOL 
Multiphysics (v 5.4) software. These models utilize time-harmonic wave propagation equation to 
calculate the electromagnetic power absorption profile in tissue. The electromagnetic model is 
coupled with the transient heat transfer equation to calculate 3D temperature profiles. Similar to 
state-of-art MWA computational models [199], [209],  changes in tissue physical properties as a 
function of temperature change were incorporated within our model. Similar to prior modeling 
studies of water-cooled microwave ablation applicators [213], [232], we employed a convective 
heat transfer boundary condition assuming a constant cooling temperature for the circulating water 
flowing inside the applicator (during ablation experiments, a 1 °C change in circulating water was 
measured, see Fig. A.S.1 in the Appendix A). Since this study only considered experiments in ex 
vivo tissue, no perfusion term was included. Fig. 5.3 illustrates the various components of the 
computational model, including specification of boundary conditions, and how the 
electromagnetic and thermal model are coupled. Further details of the computational model were 
previously described in [157]. 
Similar to existing computational models of MWA [199], we incorporated temperature-
dependent changes in tissue physical and thermal properties in our models.  
Table 5.1 lists the equations for temperature dependent tissue properties which were used in 
the computational models in this work, similar to [199]. Briefly, the dielectric properties are 
represented with a sigmoidal temperature dependency, where both relative permittivity and 
effective conductivity transition from relatively high values at low temperatures to relatively low 
values at temperatures in excess of ~100 °C (attributed to desiccation) [210], [211]. The volumetric 
heat capacity incorporates the effects of latent heat of water vaporization at temperatures close to 
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Table 5.1. Temperature dependent tissue properties for microwave ablation computational model 
Temperature dependent 
tissue properties 
Equation used in the coupled computational model of 
microwave ablation 
𝜎𝑒𝑓(𝑇) 
𝜎𝑒𝑓 . (1 −
1
1 + exp(0.0697. (85.375 + Δ𝑒𝑙 − 𝑇))
) 
𝜖𝑟(𝑇) 
𝜖𝑟 . (1 −
1
















          𝑓𝑜𝑟           (100 −
Δ𝑇
2











𝑘0 + Δ𝑘 × (𝑇 − 37)                       𝑓𝑜𝑟                  𝑇 < 100 °𝐶
𝑘0 + Δ𝑘 × (100 − 37)                      𝑓𝑜𝑟                  𝑇 > 100 °𝐶
 
 
100 °C [233].  Thermal conductivity is represented with a linear increase with increasing 
temperature, as reported in [234]. A non-uniform tetrahedral mesh grid was applied through the 
geometry such that the finest mesh was applied at the applicator input port boundry (maximum 
element edge length = 0.05 mm), with increasing element size at distant regions, with the largest 
mesh elements within the tissue domain (maximum element edge length = 3 mm).    
The Arrhenius thermal damage model is a well-established model for assessing thermal 
damage following non-isothermal heating, and was used in this study to compare model-predicted 
thermal ablation zones with experimental measurement (Equation 14): 
 









In the above equation, the frequency factor (A = 5.51×1041 s-1) and energy barrier (Ea = 
2.769×105 J.mol-1), were selected for pig liver tissue whitening [219]. R is gas constant (8.3145 J 
mol-1 k-1) and T(t) is the temperature (°C) at time t. A binary thermal damage map, showing the 
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extent of ablated area, was calculated using I = Ω(T) > 1, which corresponds to 63% of the thermal 
damage process being completed. 
 
Figure. 5.3 Schematic of the 3D microwave computational model 
5.2.3. Experimental assessment of microwave ablation computational models 
We compared 3D transient temperature profiles predicted by computational models with 
temperature profiles measured using MRT.  To consider volumetric temporal and spatial 
distribution of temperature, we made the following comparisons between simulated and measured 
temperature profiles: 
a) Transient temperature in multiple 3×3 ROIs in coronal and axial planes 
b) Radial distribution of temperature at different time-points in the duration of experiments at 
multiple locations along the axis of the MWA applicator.  
The mean absolute error (MAE %) between MRT and simulated temperature (TMRT and 
Tsimulated in equation 3, respectively) is reported for the above comparisons (a and b), as a percentage 
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of the maximum temperature change observed during experimental ablations. Equation 3 is used 
to measure MAE %: 
   𝑀𝐴𝐸 % =
𝑎𝑣𝑔|𝑇𝑀𝑅𝑇−𝑇𝑠𝑖𝑚𝑢𝑙𝑎𝑡𝑒𝑑|
𝑀𝑎𝑥(𝑇𝑀𝑅𝑇)
× 100  (14) 
MAE % is an established measure of difference between simulations and measurements 
relative to the largest measured value [213]. 
a)  Extents of the ablation zone, using binary Arrhenius thermal damage maps. To compare 
simulated and MR-derived binary Arrhenius map, Dice similarity coefficient (DSC) is 
used (Equation 4, in which I is binary Arrhenius map). 




   
5.2.4. Sensitivity analysis 
Tissue biophysical properties are known to vary considerably across patients, as well as a 
function of tissue pathological state. Prior studies of tissue dielectric and thermal properties made 
on ex vivo tissue have also demonstrated variability in these properties across samples [220]. The 
inter-sample variability of tissue dielectric and thermal properties may affect the experimental 
outcome. Similar to previous studies on sensitivity analysis of thermal ablation [199], [235], we 
used the Morris method to determine the sensitivty of microwave ablation zones to uncertainty in 
tissue physical properties. The seven variables considered for this sensitivity study and their range 
of tissue physical properties are defined and shown in Table 5.2. The equations describing the 
temperature dependence of the dielectric and thermal parameters is provided in Table 5.1. In this 
work, we have considered 30 starting points for the variables with significant influence on the 
ablation zone shape according to sensitivity study in (i.e. a total of 210 simulations).  
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Table 5.2. Range of values for tissue physical properties used in the sensitivity study 
Sensitivity 
parameters 
Definition Range Units 
εr Relative permittivity 30.73 - 68.8 - 
σef Effective conductivity 1.14 – 2.55 S/m 
∆el Temperature transition in sigmoid function  
(Temperature at which state of sigmoid function changes from high to low) 
-15 to 15 °C 
ρc0 Basline volumetric heat capacity (3.7 – 4.3). 106 J/(°C.m3) 
∆T Temperature interval across which the tissue changes phase 1 – 10 °C 
k0 Thermal conductivity 0.46 – 0.57 W/(°C.m) 
∆k Thermal conductivity change with temperature 0 – 0.0033 W/(°C.m) 
 
5.3. Results 
5.3.1. MRT validity assessment  
MRT measurements were compared against fiber-optic temperature data for a wide range of 
temperatures, with a maximum temperature rise of 100 °C monitored with FO1 at 5 mm radially 
from the ablation applicator. Prior to heating, the observed standard deviation of MRT data was in 
the range of 0.3- 0.7 °C, which provides an indication of the uncertainty in our MRT 
measurements. Fig. 5.4 shows exemplar transient temperature profiles prior to, during and post 
MWA measured with MRT and FO1 and FO2. Mean absolute error (MAE) between MRT and FO1 
and FO2 during heating across 13 ex vivo tissue MWA experiments was in the range of 1 – 2.8 °C 




Figure. 5.4 Experimental transient temperature measurments with fiber-optic temperature sensors in 
comparison to MRT at ROIs located at the tip of fiber-optic temperature probes in 5 mm (black lines) and 
30 mm (blue lines) distance from the applicator with input power of 30 and 40 W.  
5.3.2. Experimental assessment of computational models  
Fig. 5.5 shows MRT measurements from four different experiments (labeled MRT 1- MRT 4) 
during microwave ablation of ex vivo tissue compared to simulated temperatures in multiple 3×3 
ROIs in axial and coronal views. ROIs in proximity to the applicator were selected to include high 
temperatures and locations that dielectric and thermal properties of tissue were expected to change 
substantially during the ablation experiment. Conversely, ROIs further away from the applicator 
were also selected to include regions of lower temperatures. The MAE %, as a percentage of 
overall temperature rise, between experimentally measured and simulated temperatures was 
calculated for each of the transient temperature profiles shown in Fig. 5.5, which ranges between 
1.2 % and 11 % with an average of 5.91 ± 1.1 %. 
 
Figure. 5.5 Experimentally measured and simulated transient temperature profiles at multiple ROIs in 
coronal (first row) and axial views (second row) for input power P = 30 W. MAE % reports the average 
percentage of mean absolute error between MRT1, MRT2, MRT3, MRT4 and model.   
We further compared MR-measured and simulated temperatures radially at different time-
points during the MWA experiments at multiple regions of tissue relative to the applicator distal 
point (Fig. 5.6). The MAE % between radial temperatures measured using MRI map and predicted 
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by 3D model is calculated. The MAE % shown on each of the temperature profiles in Fig. 5.6, is 
the mean of the MAE % between each of the MRTs and the model-predicted temperature profile.  
 
 
Figure. 5.6 Experimentally measured and simulated radial temperature profiles located at 10 mm and 15 
mm from the applicator tip at t = 180, 300 and 600 s followed by input power of 30 W. MAE % represents 
the mean absolute error as a percentage of maximum temperature between MRT1, MRT2, MRT3, MRT4 
and simulations. 
We also compared model-predicted ablation zone extents against MRT-derived Arrhenius 
thermal damage maps in 3D view. In Fig. 5.7, three examples of Arrhenius thermal damage maps 
with different combinations of power and ablation duration are illustrated. The DSC between 
model-predicted ablation zones and MRT derived Arrhenius thermal damage maps were 0.8 ± 0.0 




Figure. 5.7 Thermal damage boundaries of MRT measured, coupled and uncoupled simulated arrhenuis 
map superimposed on the magnitude image collected a) with input power of 30 W  after 300 s, b) with input 
power of 30 W after 600 s and c) with input power of 50 W followed by 300 s of ablation. 
Fig. 5.8 depicts the variation of MRT-derived Arrhenius thermal damage maps across ex vivo 
tissue experiments. We have averaged the binary thermal damage maps computed from MRT 
measurements during ex vivo tissue MWA experiments for each particular power and time 
combination. This illustration provides an assessment of the variability of ablation outcome across 
multiple experiments. Regions which were ablated in all experiments yielded an average value of 
1, while regions not ablated in any of the experiments yielded an average value of 0. Regions 
where the average value was between 0 and 1 were ablated in a subset of experiments.  A single 
model-predicted thermal damage contour, using the average value of tissue physical properties, is 
superimposed on the averaged thermal damage map. As shown in Fig. 5.8, the simulated thermal 
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damage contour is in alignment with the ablated region that is in common among all ex vivo tissue 
MWA experiments (white regions in Fig. 5.8).  
 
Figure. 5.8 Experimentally measured Arrhenuis thermal damage maps averaged across multiple 
experiments, superimposed on the simulated arrhenuis map; white regions indicate ablation zones in 
common between all MRT-derived Arrhenuis thermal damage map, gray regions are areas ablated in  a 
subset of experiments, and black regions are non-ablated tissues across all experiments.    
The sensitivity of simulated experimental profiles to uncertain tissue dielectric and thermal 
properties and their temperature dependecies, is illustrated in Fig. 5.9. The data are presented as 
the average of the binary ablation maps across multiple experiments. Also illustrated are 20%, 
50%, and 100% contours from both simulations and experiments, which provide an interpretation 
of the likelihood of ablation for a given location.  
5.4. Discussion 
Validation of MWA computational models would contribute to applying models to their full 
potential for ablation device design and characterization, comparative assessment of energy 
delivery strategies, and patient-specific pre-treatment planning. The objective of this work was to 
integrate a MWA system with 3T MRI, and to use the volumetric MR thermometry as a means for 
validating computational models. The MR-guided MWA platform that we developed offered 3D 
temperature measurements during ablation experiments in ex vivo tissue, facilitating comparison 
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against simulated temperatures in both axial and coronal planes. The present study considered an 
MWA applicator with a cylindrically symmetric pattern, 
 
Figure. 5.9 Probability of tissue being ablated in experimentally measured and simulated Arrhenuis thermal 
damage map with P = 30 W followed by (a) 5 min and (b) 10 min ablation duration. 210 simulations and 
NMRT number of MR-guided experiments were used to calculate the probability map.  
similar to applicators in current clinical use, inserted within a homogenous medium. If evaluating 
thermal ablation profiles within more heterogeneous media, as in the clinical context, or when 
considering emerging MWA applicators with directional control of radiation [236], measurement 
of the 3D temperature profiles and ablation patterns enabled by the presented technique would 
offer considerably more detailed characterization of ablation profiles in contrast to the widely-used 
point-based temperature measurement which enables model assessment at only a few discrete 
points [213].  Evaluating the performance of computational models by insertion of few temperature 
probes not only monitors temperature in just few points at the location of temperature probes but 
it presents source of variability due to the inherent uncertainty in accurately localizing the 
temperature probe position relative to the ablation applicator. 
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Similar to several other prior studies [228]–[230], we employed fast spoiled GRE sequence 
(FLASH on Siemens scanners and SPGR on GE scanners) as the thermometry sequence. This 
sequence was selected as it has previously been validated for MR thermometry monitoring of 
ablation, although it is noted that several other thermometry sequences are available for monitoring 
tissue ablation, as reviewed in [120]. Since MRT measurements are known to be sensitive to B0 
magnetic field inhomogeneity, which can be affected by the insertion of MWA applicator, we 
measured temperature changes in an agar phantom within regions of interest in proximity to the 
MWA applicator (5 mm) and distant (27 mm) from the applicator. Without any applied microwave 
power (i.e. no heating), standard deviation of MRT data over time at 5 mm was in the range of 
0.38 – 0.47 °C, while the standard deviation of MRT data over time at 27 mm was in the range 
0.37 – 0.41 °C. These results indicate that introducing our applicator into the tissue did not have a 
significant impact on the uncertainty of MRT data (see Fig. A.S.2 in the Appendix A). While prior 
studies [231] noted considerable impact of artifacts in proximity to metallic ablation probes, 
limited artifact may have been observed in the present study since the water-cooled ablation 
applicator does not have any metallic components in direct contact with tissue; rather, the antenna 
is surrounded by circulating water that is enclosed by plastic tubes. 
Temperature profiles measured by MRT were used to comparatively assess the validity of 
the MWA computational model (Fig. 5.5 and Fig. 5.6). The mean absolute error (MAE %), 
expressed as a percentage of maximum change in temperature, of MRT measured and model 
predicted temperatures at different ROIs was 5.91 ± 1.1 %. Radial temperature profiles at multiple 
time-points during the experiment and different locations relative to the distal point of the 
applicator were then compared. As a result of this comparison, the average of MAE % was 7.4 ± 
0.7. These data indicate that although discrepancies between model predicted and experimentally 
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measured temperatures can be quite large, in regions at the periphery of the ablation zone, 
simulated and measured temperatures are generally well aligned.  We note that the presence of the 
MWA applicator may cause an artifact in the anatomical (i.e. magnitude) images acquired by 
FLASH sequence [237]. This may decrease the accuracy of locating the MWA applicator tip, 
which was used as a reference for temperature comparison between experimental and simulated 
temperatures. This may also be a source of discrepancy between MR-measured and simulated 
temperatures at different ROIs or radially measured temperatures especially in the proximity of 
the applicator (Fig. 5.5 and 5.6). We also anticipate the asymmetric water inflow inside the 
applicator as another potential source of discrepancy. While fabricating the microwave applicator, 
we attempted to center the inner conductor in the water inflow tube, however, it may have been 
slightly shifted toward one side of the water inlet tubing. In this case, the cooling effect would be 
higher on one side of the applicator relative to the other side while the cooling effect remains 
symmetric within the computational model. In Fig. 5.6, the discrepancy in the temperature 
measurements that are distances further from the applicator are primarily in regions with blood 
vessels, that are filled with air in this ex vivo tissue model. 
A widely used approach for validation of MWA computational models is to compare 
experimental measurements of the extent of visible tissue discoloration, with simulated ablation 
zone, either using a thermal damage model, or with a temperature isotherm [10]. Another widely 
used approach is to compare transient temperatures at select discrete points with model predictions 
at corresponding locations [209]–[211]. Volumetric assessment, with MRT, enables both spatial 
and temporal comparison of temperature profiles and ablation zone size and shape (Fig. 5.7 and 
Fig. 5.8). It’s noteworthy that in a few experiments, high power microwave exposure, P > 40 W 
(n = 4) or long duration of ablation exposure, t = 600 s (n = 2) were associated with extensive 
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water vaporization in proximity to the applicator, which corrupted MRT data in these regions. The 
discontinuity in the thermal damage profile of the transaxial views of Fig. 5.7 (c) is a result of this 
incident. Due to this limitation, conventional MRT measurements may not be an appropriate 
technique for monitoring tissue temperatures reaching elevated temperatures in excess of 100 °C, 
as are commonly observed during MWA. In spite of this limitation, the ability of MRT to provide 
volumetric assessment of ablation profiles, as well as accurately capture transient temperature 
profiles in regions below 100 °C, offers considerable added information over probe-based 
thermometry techniques.  
  We found the area of regions ablated in all experiments was 283 mm2, and the area of 
regions ablated in only one experiment was 411 mm2 (Figs. 5.8 and 5.9). In contrast, the 
corresponding areas of these regions in simulations were 327 mm2 and 395 mm2, respectively, 
after conducting 210 simulations using the Morris method. The relatively smaller difference 
between these areas in simulation suggests that, for the power levels and ablation durations 
considered in this study, the ablation zone is relatively insensitive to variability in tissue physical 
properties. This may be attributed to the applicator design, where the antenna is surrounded by a 
relatively static, high dielectric constant medium, achieved by circulating chilled water through 
the applicator up to the distal radiating tip. Prior sensitivity studies of MWA [199], [238] suggested 
larger variations due to uncertainty in tissue properties, but the antennas considered in those studies 
did not have water circulated to the radiating tip. The relatively larger variations observed in 
experiments may be due to additional sources of uncertainty not accounted for within simulations. 
These include variations in MRT slice localization relative to the applicator across various 
simulations and ablation zones affected by steam transport within vessels during these ex vivo 
tissue experiments. Nevertheless, the 100% contours from experiments and simulations were 283 
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mm2 and 327 mm2 and, the 50% contours from experiments and simulations were 503 mm2 and 
406 mm2, respectively, indicating the model’s ability to represent the ablation zone profiles 
observed experimentally.  
This study had several limitations. During MWA, the center of ablation region in the 
proximity of applicator loses water first and the water is driven outwards, evaporates and may 
recondense in cooler regions away from the applicator [209], [239]. This effect was not 
incorporated in the 3D computational model we used for the assessment. Furthermore, changes in 
tissue physical properties at elevated temperatures (Table 5.1) were modeled as functions of 
temperature alone, based on the currently available models in the literature. However, it is 
plausible that tissue properties may also be a function of rate of heating, in addition to temperature. 
The impact of rate of heating and tissue water transport may be of most significance in proximity 
to the applicator, where the highest temperatures are observed, and could thus have contributed to 
the discrepancy between model and experiment in these regions.  However, not accounting for 
these changes is not anticipated to have a significant impact on the extent of the ablation zone, 
which is governed by more temperatures at distances ~10-15 mm from the applicator [209]. 
Furthermore, our computational models did not account for tissue shrinkage [240], [241].  
5.5. Conclusion 
We have developed a system for characterizing 3D transient temperature profiles with MR 
thermometry in ex vivo tissue during 2.45 GHz MWA, and applied the system for experimental 
validation of MWA computational models. Experimentally measured and simulated temperatures 
as a function of time and distance were compared at multiple locations along the MWA applicator 
length and were in agreement with DSC in the range of 0.75 – 0.8. Ablation zone shape was also 
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compared between MRT-derived and model-predicted using thermal damage profile. The average 
of MAE % were in the range of 5 % – 8.5 %. These results report on the validity of transient 
temperature and ablation profiles predicted by the state-of-art computational models of microwave 
ablation and pave the way for further development and investigation of models for ultimate 






6. Conclusion and potential directions for further work 
This dissertation contributes to the development of thermal therapy systems. Hyperthermia 
and ablation systems were modelled in 3D, configured and tested in vivo in small-animals and in 
ex vivo tissues, paving the path for further investigation to reach the ultimate goal which is 
development of technologies to address unmet healthcare needs.  
To develop thermal therapy systems, one of the most important steps is designing an 
application-specific device (key element 3). This is often implemented by integrating 
computational modelling and prototyping and experimental evaluation. A significant challenge 
when using the 3D computational models for device design is the question of model validity (Key 
element 2).  In chapter 3 and 4 experimental validation of computational model were considered 
as a first step to enable further investigations of application and tissue-specific models. Chapter 5 
is particularly dedicated to assessing the validity of state-of-art microwave ablation 3D 
computational models. We developed a system for 2.45 GHz MWA integrated with MRI at 3T, 
and applied the system experimental validation of MWA computational models. In this 
dissertation, experimentally validated computational models are then used for device design and 
characterization for specific tissue and application as follow: 
For specific tissue; we have employed experimentally validated microwave ablation 
computational models to evaluate the effect of presence of fibroids (abnormal uterine muscle 
growth) on endometrial ablation profile (chapter 4).  
A possible future direction is to investigate the sensitivity of endometrial ablation profile 
to the presence of fibroid using microwave ablation computational models incorporating 
temperature dependent dielectric properties at 915 MHz that are recently measured in [242].  This 
could not be done at the time the research conducted in this dissertation was performed due to the 
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lack of published data on uterine fibroid dielectric properties, and their temperature dependencies. 
As this data becomes available from experimental studies, incorporating them into computational 
models would further enhance the utility of the modeling work presented in this dissertation.   
For specific application; In chapter 3, we have developed a small-animal hyperthermia 
platform, to locally deliver energy to the target while thermally sparing the surroundings. To 
implement this, we used a model-based approach to design and characterize a microwave 
applicator and fabricated and tested the optimized applicator experimentally in both agar phantom 
and in vivo in mice. Since the creation of this device, devices have been shared with research 
groups at external institutions who are investigating its use in experimental studies involving 
triggered drug release from temperature-sensitive liposomes.  
A possible future research direction is to investigate the validity of computational model 
in vivo in integration with 3T MRI. Developing an in vivo ablation platform integrated with MR 
thermometry may be challenging due to the presence of motion and blood perfusion. Motion 
compensation techniques may be applied to correct MRI estimates of temperature during the 
ablation experiments [243]–[245].  
Real-time temperature monitoring is one of the main challenges of thermal therapy system 
developments (Key element 1). A combination of temperature and time is an indicator of the 
thermal dose delivery to the target. Therefore, measuring temperature during the heating 
experiment is of high significance, particularly for hyperthermia platform, where tissue 
temperature needs to be regulated within a narrow range. Real time monitoring of tissue 
temperature is a necessity for hyperthermia systems in order to ensure the delivered temperature 
profile is within the hyperthermic range to avoid irreversible thermal damage to the tissue. 
Temperature rise beyond the hyperthermic range could eliminate the hyperthermia-induced 
99 
 
physiological effects. Different methods for temperature monitoring during the heat exposure was 
reviewed in chapter 2. We developed a microwave hyperthermia system integrated with a 14 T 
ultra-high field small-animal MRI scanner to facilitate real-time temperature monitoring with MR 
thermometry. We implemented a real-time temperature-based feedback control to keep the target 
temperature in the desired range for prolonged period of time (chapter 3).  
A possible direction for future research is to incorporate the developed hyperthermia 
platform to investigate the effect of heat on the immune system behavior in small - animals [246], 
[247] and to integrate temperature sensitive liposomes for drug delivery to the tumor site and 
implement a comparative assessment to study the density and performance of delivered drug in 
the absence and presence of heat [248]–[250].  
In reference to above, the main contributions of this dissertation are: (1) assessing the 
validity microwave ablation computational models volumetrically in comparison to existing 
methods in literature such as using temperature sensors in few points or superficial temperature 
measurements with infrared cameras; (2) designing a 2.45 GHz microwave applicator integrated 
in a hyperthermia platform to focus heating to the tumor volume located at 1 - 3 mm from the skin 
surface, with minimal heating of the surrounding tissue; (3) development of small-animal 
hyperthermia platform with real-time temperature monitoring and input energy control schemes; 
(4) showing the impact of uterine fibroids on the extent of microwave endometrial ablation patterns 
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Appendix A - Experimental assessment of microwave ablation 
computational modeling with MR thermometry – Supplementary 
data 
To evaluate the modelled water flow in the MWA applicator during the course of heating, we 
measured temperature of water at the applicator inlet and outlet during ablation experiment. When 
using an input power of 30 W (at the applicator), change in temperature of the inflowing water 
was ~ 1 - 2 ˚C over the duration of the 10 min experiment. During the 5 min ablation experiment 
at 50 W, change in temperature of inflowing water was ~ 1 ˚C. The figure below shows the 
measured temperature changes for inflowing/outflowing water during the experiments. Based on 
these experiments, we anticipate a 1 ˚C change in the circulating water temperature, and that these 
would not be expected to have a significant effect on tissue temperatures and ablation zone extents.  
 
Fig. A.S.1. Experimental transient temperature measurments with fiber-optic temperature sensors in the 




To assess the potential impact of susceptibility artifact on the uncertainty of MR thermometry 
in proximity to the antenna, we compared the uncertainty of temperature measurements in an agar 
phantom, in ROIs positioned  in proximity to (5 mm) and distant from (27 mm) the applicator (see 
Fig. A.S.2). With no applied microwave power, the temperature change in all regions of the 
phantom was anticipated to be zero. As shown in the figure, the standard deviation in the proximity 
(5 mm) of MWA applicator over time is in the range of 0.38 – 0.47 °C while the standard deviation 
further away from the applicator (27 mm) is in the range of 0.37 – 0.41 °C. The difference between 
the temperature change in the ROIs close to the applicator and ROIs further away is minimal. 
Thus, we concluded that the susceptibility artifacts in proximity to the applicator had negligible 
impact on MR thermometry. 
 
Fig. A.S.2. MRT-measured transient temperature in agar phantom in ROIs in the proximity (5 mm) and 
distant (27 mm) from the MWA applicator in the absence of heat.  
 
 
